BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Young LS, Yap LF, Murray PG. Epstein-Barr virus: more than 50 years old and still providing surprises. Nat Rev Cancer. 2016;16:789-802. [PMID: 27687982 DOI: 10.1038/nrc.2016.92] [Cited by in Crossref: 296] [Cited by in F6Publishing: 287] [Article Influence: 49.3] [Reference Citation Analysis]
Number Citing Articles
1 Malecka KA, Dheekollu J, Deakyne JS, Wiedmer A, Ramirez UD, Lieberman PM, Messick TE. Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication. J Virol 2019;93:e00487-19. [PMID: 31142669 DOI: 10.1128/JVI.00487-19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
2 Hu J, Li Y, Li H, Shi F, Xie L, Zhao L, Tang M, Luo X, Jia W, Fan J, Zhou J, Gao Q, Qiu S, Wu W, Zhang X, Liao W, Bode AM, Cao Y. Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy. Theranostics 2020;10:11921-37. [DOI: 10.7150/thno.46006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
3 Manara F, Jay A, Odongo GA, Mure F, Maroui MA, Diederichs A, Sirand C, Cuenin C, Granai M, Mundo L, Hernandez-Vargas H, Lazzi S, Khoueiry R, Gruffat H, Herceg Z, Accardi R. Epigenetic Alteration of the Cancer-Related Gene TGFBI in B Cells Infected with Epstein-Barr Virus and Exposed to Aflatoxin B1: Potential Role in Burkitt Lymphoma Development. Cancers (Basel) 2022;14:1284. [PMID: 35267594 DOI: 10.3390/cancers14051284] [Reference Citation Analysis]
4 Li J, Liu W, Che K, Zhang Y, Zhao Z, Luo B. The Methylation Status and Expression of Epstein-Barr Virus Early Genes BARF1 and BHRF1 in Epstein-Barr Virus-Associated Gastric Carcinomas. Gastroenterol Res Pract 2017;2017:3804146. [PMID: 28487730 DOI: 10.1155/2017/3804146] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
5 Corvalán AH, Ruedlinger J, de Mayo T, Polakovicova I, Gonzalez-Hormazabal P, Aguayo F. The Phylogeographic Diversity of EBV and Admixed Ancestry in the Americas⁻Another Model of Disrupted Human-Pathogen Co-Evolution. Cancers (Basel) 2019;11:E217. [PMID: 30769835 DOI: 10.3390/cancers11020217] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Xu S, Zhou Z, Peng X, Tao X, Zhou P, Zhang K, Peng J, Li D, Shen L, Yang L. EBV-LMP1 promotes radioresistance by inducing protective autophagy through BNIP3 in nasopharyngeal carcinoma. Cell Death Dis 2021;12:344. [PMID: 33795637 DOI: 10.1038/s41419-021-03639-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Müller-coan BG, Caetano BFR, Pagano JS, Elgui de Oliveira D. Cancer Progression Goes Viral: The Role of Oncoviruses in Aggressiveness of Malignancies. Trends in Cancer 2018;4:485-98. [DOI: 10.1016/j.trecan.2018.04.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
8 El-Amrani-Joutey M, Jiménez-García R, Linares-García-Valdecasas R, Palomar-Gallego MA, Jiménez-Trujillo I, López-de-Andrés A, Vázquez-Vázquez L. Infection by Epstein-Barr virus in Fes (Morocco). Prevalence and predictors of positivity in nasopharyngeal cancer. J Infect Public Health 2018;11:807-11. [PMID: 29871843 DOI: 10.1016/j.jiph.2018.05.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
9 Douam F, Ploss A. The use of humanized mice for studies of viral pathogenesis and immunity. Curr Opin Virol 2018;29:62-71. [PMID: 29604551 DOI: 10.1016/j.coviro.2018.03.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
10 Ishikawa E, Satou A, Nakamura M, Nakamura S, Fujishiro M. Epstein-Barr Virus Positive B-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract. Cancers (Basel) 2021;13:3815. [PMID: 34359715 DOI: 10.3390/cancers13153815] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Messick TE, Tolvinski L, Zartler ER, Moberg A, Frostell Å, Smith GR, Reitz AB, Lieberman PM. Biophysical Screens Identify Fragments That Bind to the Viral DNA-Binding Proteins EBNA1 and LANA. Molecules 2020;25:E1760. [PMID: 32290261 DOI: 10.3390/molecules25071760] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Edelbrock RM, Thapa B, Fritz MA, Recinos P, Borghei-Razavi H. Primary Infectious Mononucleosis Masquerading as Post-operative Fever in a Young Patient with Cemento-ossifying Fibroma of the Skull Base. Cureus 2019;11:e6327. [PMID: 31938618 DOI: 10.7759/cureus.6327] [Reference Citation Analysis]
13 Stanland LJ, Luftig MA. The Role of EBV-Induced Hypermethylation in Gastric Cancer Tumorigenesis. Viruses 2020;12:E1222. [PMID: 33126718 DOI: 10.3390/v12111222] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
14 Satou A, Takahara T, Nakamura S. An Update on the Pathology and Molecular Features of Hodgkin Lymphoma. Cancers 2022;14:2647. [DOI: 10.3390/cancers14112647] [Reference Citation Analysis]
15 Jhang J, Hsu Y, Peng C, Jiang Y, Ho H, Kuo H. Epstein-Barr Virus as a Potential Etiology of Persistent Bladder Inflammation in Human Interstitial Cystitis/Bladder Pain Syndrome. Journal of Urology 2018;200:590-6. [DOI: 10.1016/j.juro.2018.03.133] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
16 Van Sciver N, Ohashi M, Nawandar DM, Pauly NP, Lee D, Makielski KR, Bristol JA, Tsao SW, Lambert PF, Johannsen EC, Kenney SC. ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells. PLoS Pathog 2021;17:e1010045. [PMID: 34748616 DOI: 10.1371/journal.ppat.1010045] [Reference Citation Analysis]
17 Zhu QY, Zhao GX, Li Y, Talakatta G, Mai HQ, Le QT, Young LS, Zeng MS. Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma. MedComm (2020) 2021;2:175-206. [PMID: 34766141 DOI: 10.1002/mco2.32] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Chung YL, Wu ML. Clonal dynamics of tumor-infiltrating T-cell receptor beta-chain repertoires in the peripheral blood in response to concurrent chemoradiotherapy for Epstein-Barr virus-associated nasopharyngeal carcinoma. Oncoimmunology 2021;10:1968172. [PMID: 34513316 DOI: 10.1080/2162402X.2021.1968172] [Reference Citation Analysis]
19 Dollery SJ, Santiago-Crespo RJ, Chatterjee D, Berger EA. Glycoprotein K8.1A of Kaposi's Sarcoma-Associated Herpesvirus Is a Critical B Cell Tropism Determinant Independent of Its Heparan Sulfate Binding Activity. J Virol 2019;93:e01876-18. [PMID: 30567992 DOI: 10.1128/JVI.01876-18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
20 Wojtak K, Perales-Puchalt A, Weiner DB. Novel Synthetic DNA Immunogens Targeting Latent Expressed Antigens of Epstein-Barr Virus Elicit Potent Cellular Responses and Inhibit Tumor Growth. Vaccines (Basel) 2019;7:E44. [PMID: 31137606 DOI: 10.3390/vaccines7020044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
21 Sirbu AM, Sirbu CA, Eftimie L, Soare AM, Ghinescu MC, Ionita-Radu F. Multiple sclerosis, human herpesvirus 4 and thyroid collision tumor: A case report. Exp Ther Med 2020;20:3458-61. [PMID: 32905114 DOI: 10.3892/etm.2020.8975] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
22 Kozireva S, Rudevica Z, Baryshev M, Leonciks A, Kashuba E, Kholodnyuk I. Upregulation of the Chemokine Receptor CCR2B in Epstein‒Barr Virus-Positive Burkitt Lymphoma Cell Lines with the Latency III Program. Viruses 2018;10:E239. [PMID: 29751565 DOI: 10.3390/v10050239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Simoni Y, Becht E, Li S, Loh CY, Yeong JPS, Lim TKH, Takano A, Tan DSW, Newell EW. Partial absence of PD-1 expression by tumor-infiltrating EBV-specific CD8+ T cells in EBV-driven lymphoepithelioma-like carcinoma. Clin Transl Immunology 2020;9:e1175. [PMID: 32995000 DOI: 10.1002/cti2.1175] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Rühl J, Citterio C, Engelmann C, Haigh T, Dzionek A, Dreyer J, Khanna R, Taylor GS, Wilson JB, Leung CS, Münz C. Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomas. J Clin Invest 2019;129:2071-87. [PMID: 31042161 DOI: 10.1172/JCI125364] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 8.7] [Reference Citation Analysis]
25 Lasaviciute G, Björkander S, Carvalho-Queiroz C, Hed Myrberg I, Nussbaum B, Nilsson C, Bemark M, Nilsson A, Sverremark-Ekström E, Saghafian-Hedengren S. Epstein-Barr Virus, but Not Cytomegalovirus, Latency Accelerates the Decay of Childhood Measles and Rubella Vaccine Responses-A 10-Year Follow-up of a Swedish Birth Cohort. Front Immunol 2017;8:1865. [PMID: 29312344 DOI: 10.3389/fimmu.2017.01865] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
26 Chen X, Kost J, Sulovari A, Wong N, Liang WS, Cao J, Li D. A virome-wide clonal integration analysis platform for discovering cancer viral etiology. Genome Res 2019;29:819-30. [PMID: 30872350 DOI: 10.1101/gr.242529.118] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
27 .McDougall WM, Perreira JM, Reynolds EC, Brass AL. CRISPR genetic screens to discover host–virus interactions. Current Opinion in Virology 2018;29:87-100. [DOI: 10.1016/j.coviro.2018.03.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
28 Tsai MS, Newman C, Macdonald DW, Buesching CD. Stress-Related Herpesvirus Reactivation in Badgers Can Result in Clostridium Proliferation. Ecohealth 2021. [PMID: 34870778 DOI: 10.1007/s10393-021-01568-2] [Reference Citation Analysis]
29 Yu H, Yin X, Mao Y, Chen M, Tang Q, Yan S. The global burden of nasopharyngeal carcinoma from 2009 to 2019: an observational study based on the Global Burden of Disease Study 2019. Eur Arch Otorhinolaryngol 2021. [PMID: 34146150 DOI: 10.1007/s00405-021-06922-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Van Sciver N, Ohashi M, Pauly NP, Bristol JA, Nelson SE, Johannsen EC, Kenney SC. Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells. PLoS Pathog 2021;17:e1009783. [PMID: 34339458 DOI: 10.1371/journal.ppat.1009783] [Reference Citation Analysis]
31 Zhu S, Chen J, Xiong Y, Kamara S, Gu M, Tang W, Chen S, Dong H, Xue X, Zheng ZM, Zhang L. Novel EBV LMP-2-affibody and affitoxin in molecular imaging and targeted therapy of nasopharyngeal carcinoma. PLoS Pathog 2020;16:e1008223. [PMID: 31905218 DOI: 10.1371/journal.ppat.1008223] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
32 Lin LY, Bhate K, Forbes H, Smeeth L, Warren-Gash C, Langan S. Vitamin D deficiency or supplementation and the risk of human herpesvirus infections or reactivation: a systematic review protocol. BMJ Open 2019;9:e031867. [PMID: 31594899 DOI: 10.1136/bmjopen-2019-031867] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Smatti MK, Al-Sadeq DW, Ali NH, Pintus G, Abou-Saleh H, Nasrallah GK. Epstein-Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update. Front Oncol. 2018;8:211. [PMID: 29951372 DOI: 10.3389/fonc.2018.00211] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 16.3] [Reference Citation Analysis]
34 Montes L, Tredez E, Yzet C, Delette C, Chatelain D, Lebon D, Fumery M, Marolleau JP. Epstein-Barr Virus-related mucocutaneous ulcer lymphoma associated with Crohn's disease, treated with monoclonal antibody anti-CD30. Clin Case Rep 2020;8:958-61. [PMID: 32577242 DOI: 10.1002/ccr3.2721] [Reference Citation Analysis]
35 Tsang CM, Lui VWY, Bruce JP, Pugh TJ, Lo KW. Translational genomics of nasopharyngeal cancer. Semin Cancer Biol 2020;61:84-100. [PMID: 31521748 DOI: 10.1016/j.semcancer.2019.09.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
36 Fiches GN, Zhou D, Kong W, Biswas A, Ahmed EH, Baiocchi RA, Zhu J, Santoso N. Profiling of immune related genes silenced in EBV-positive gastric carcinoma identified novel restriction factors of human gammaherpesviruses. PLoS Pathog 2020;16:e1008778. [PMID: 32841292 DOI: 10.1371/journal.ppat.1008778] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
37 Vistarop AG, Cohen M, Huaman F, Irazu L, Rodriguez M, De Matteo E, Preciado MV, Chabay PA. The interplay between local immune response and Epstein-Barr virus-infected tonsillar cells could lead to viral infection control. Med Microbiol Immunol 2018;207:319-27. [PMID: 30046954 DOI: 10.1007/s00430-018-0553-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
38 Voigt S, Sterz KR, Giehler F, Mohr AW, Wilson JB, Moosmann A, Kieser A. A central role of IKK2 and TPL2 in JNK activation and viral B-cell transformation. Nat Commun 2020;11:685. [PMID: 32019925 DOI: 10.1038/s41467-020-14502-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
39 Yu S, Yang Q, Wu J, Zhu M, Ai J, Zhang H, Xu B, Shao L, Zhang W. Clinical application of Epstein-Barr virus DNA loads in Epstein-Barr virus-associated diseases: A cohort study. J Infect 2021;82:105-11. [PMID: 33248217 DOI: 10.1016/j.jinf.2020.11.027] [Reference Citation Analysis]
40 Varga MG, Cai H, Waterboer T, Murphy G, Shimazu T, Taylor PR, Qiao YL, Park SK, Yoo KY, Jee SH, Cho ER, Kim J, Abnet CC, Tsugane S, Cai Q, Zheng W, Pawlita M, Shu XO, Epplein M. Epstein-Barr Virus Antibody Titers Are Not Associated with Gastric Cancer Risk in East Asia. Dig Dis Sci 2018;63:2765-72. [PMID: 29948559 DOI: 10.1007/s10620-018-5154-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
41 Shannon-Lowe C, Rickinson AB, Bell AI. Epstein-Barr virus-associated lymphomas. Philos Trans R Soc Lond B Biol Sci. 2017;372. [PMID: 28893938 DOI: 10.1098/rstb.2016.0271] [Cited by in Crossref: 136] [Cited by in F6Publishing: 132] [Article Influence: 34.0] [Reference Citation Analysis]
42 De Leo A, Calderon A, Lieberman PM. Control of Viral Latency by Episome Maintenance Proteins. Trends Microbiol 2020;28:150-62. [PMID: 31624007 DOI: 10.1016/j.tim.2019.09.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
43 Chen Y, Fachko D, Ivanov NS, Skinner CM, Skalsky RL. Epstein-Barr virus microRNAs regulate B cell receptor signal transduction and lytic reactivation. PLoS Pathog 2019;15:e1007535. [PMID: 30615681 DOI: 10.1371/journal.ppat.1007535] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
44 Sadato D, Ogawa M, Hirama C, Hishima T, Horiguchi SI, Harada Y, Shimoyama T, Itokawa M, Ohashi K, Oboki K. Potential prognostic impact of EBV RNA-seq reads in gastric cancer: a reanalysis of The Cancer Genome Atlas cohort. FEBS Open Bio 2020;10:455-67. [PMID: 31991047 DOI: 10.1002/2211-5463.12803] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Rizzo AG, Orlando A, Gallo E, Bisanti A, Sferrazza S, Montalbano LM, Macaluso FS, Cottone M. Is Epstein-Barr virus infection associated with the pathogenesis of microscopic colitis? J Clin Virol 2017;97:1-3. [PMID: 29078077 DOI: 10.1016/j.jcv.2017.10.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
46 Alston CI, Dix RD. SOCS and Herpesviruses, With Emphasis on Cytomegalovirus Retinitis. Front Immunol 2019;10:732. [PMID: 31031749 DOI: 10.3389/fimmu.2019.00732] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
47 Tan KE, Lim YY. Viruses join the circular RNA world. FEBS J 2021;288:4488-502. [PMID: 33236482 DOI: 10.1111/febs.15639] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
48 Sharifipour S, Davoodi Rad K. Seroprevalence of Epstein-Barr virus among children and adults in Tehran, Iran. New Microbes New Infect 2020;34:100641. [PMID: 32025310 DOI: 10.1016/j.nmni.2019.100641] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
49 Liu C, Clark PA, Kuo JS, Kalejta RF. Human Cytomegalovirus-Infected Glioblastoma Cells Display Stem Cell-Like Phenotypes. mSphere 2017;2:e00137-17. [PMID: 28656174 DOI: 10.1128/mSphere.00137-17] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
50 Lv DW, Zhang K, Li R. Interferon regulatory factor 8 regulates caspase-1 expression to facilitate Epstein-Barr virus reactivation in response to B cell receptor stimulation and chemical induction. PLoS Pathog 2018;14:e1006868. [PMID: 29357389 DOI: 10.1371/journal.ppat.1006868] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
51 Danielsson K, Nylander E, Sjöström M, Ebrahimi M. Epstein-Barr virus is not detected in mucosal lichen planus. Med Oral Patol Oral Cir Bucal 2018;23:e560-3. [PMID: 30148472 DOI: 10.4317/medoral.22617] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
52 Granato M. Nanotechnology Frontiers in γ-Herpesviruses Treatments. Int J Mol Sci 2021;22:11407. [PMID: 34768838 DOI: 10.3390/ijms222111407] [Reference Citation Analysis]
53 Yang B, Fang X, Kong J. In Situ Sampling and Monitoring Cell-Free DNA of the Epstein–Barr Virus from Dermal Interstitial Fluid Using Wearable Microneedle Patches. ACS Appl Mater Interfaces 2019;11:38448-58. [DOI: 10.1021/acsami.9b12244] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
54 Šudomová M, Berchová-Bímová K, Marzocco S, Liskova A, Kubatka P, Hassan STS. Berberine in Human Oncogenic Herpesvirus Infections and Their Linked Cancers. Viruses 2021;13:1014. [PMID: 34071559 DOI: 10.3390/v13061014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
55 Choi IK, Wang Z, Ke Q, Hong M, Qian Y, Zhao X, Liu Y, Kim HJ, Ritz J, Cantor H, Rajewsky K, Wucherpfennig KW, Zhang B. Signaling by the Epstein-Barr virus LMP1 protein induces potent cytotoxic CD4+ and CD8+ T cell responses. Proc Natl Acad Sci U S A 2018;115:E686-95. [PMID: 29311309 DOI: 10.1073/pnas.1713607115] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
56 Polepole P, Mudenda VC, Munsaka SM, Zhang L. Spectrum of common Hodgkin lymphoma and non-Hodgkin lymphomas subtypes in Zambia: a 3-year records review. J Health Popul Nutr 2021;40:37. [PMID: 34425908 DOI: 10.1186/s41043-021-00261-y] [Reference Citation Analysis]
57 Zanelli M, Sanguedolce F, Palicelli A, Zizzo M, Martino G, Caprera C, Fragliasso V, Soriano A, Gozzi F, Cimino L, Masia F, Moretti M, Foroni M, De Marco L, Pellegrini D, De Raeve H, Ricci S, Tamagnini I, Tafuni A, Cavazza A, Merli F, Pileri SA, Ascani S. EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3). Cancers (Basel) 2021;13:6021. [PMID: 34885131 DOI: 10.3390/cancers13236021] [Reference Citation Analysis]
58 Xia TL, Li X, Wang X, Zhu YJ, Zhang H, Cheng W, Chen ML, Ye Y, Li Y, Zhang A, Dai DL, Zhu QY, Yuan L, Zheng J, Huang H, Chen SQ, Xiao ZW, Wang HB, Roy G, Zhong Q, Lin D, Zeng YX, Wang J, Zhao B, Gewurz BE, Chen J, Zuo Z, Zeng MS. N(6)-methyladenosine-binding protein YTHDF1 suppresses EBV replication and promotes EBV RNA decay. EMBO Rep 2021;22:e50128. [PMID: 33605073 DOI: 10.15252/embr.202050128] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
59 Blanco R, Aguayo F. Role of BamHI-A Rightward Frame 1 in Epstein-Barr Virus-Associated Epithelial Malignancies. Biology (Basel) 2020;9:E461. [PMID: 33322292 DOI: 10.3390/biology9120461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
60 Teow SY, Liew K, Khoo AS, Peh SC. Pathogenic Role of Exosomes in Epstein-Barr Virus (EBV)-Associated Cancers. Int J Biol Sci 2017;13:1276-86. [PMID: 29104494 DOI: 10.7150/ijbs.19531] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
61 Badierah RA, Uversky VN, Redwan EM. Dancing with Trojan horses: an interplay between the extracellular vesicles and viruses. Journal of Biomolecular Structure and Dynamics 2021;39:3034-60. [DOI: 10.1080/07391102.2020.1756409] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
62 Choi SJ, Ryu E, Lee S, Huh S, Shin YS, Kang BW, Kim JG, Cho H, Kang H. Adenosine Induces EBV Lytic Reactivation through ADORA1 in EBV-Associated Gastric Carcinoma. Int J Mol Sci 2019;20:E1286. [PMID: 30875759 DOI: 10.3390/ijms20061286] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
63 Vistarop A, Jimenez O, Cohen M, De Matteo E, Preciado MV, Chabay P. Differences in Epstein-Barr Virus Characteristics and Viral-Related Microenvironment Could Be Responsible for Lymphomagenesis in Children. Pathogens 2020;9:E68. [PMID: 31963774 DOI: 10.3390/pathogens9010068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
64 Pei Y, Banerjee S, Jha HC, Sun Z, Robertson ES. An essential EBV latent antigen 3C binds Bcl6 for targeted degradation and cell proliferation. PLoS Pathog 2017;13:e1006500. [PMID: 28738086 DOI: 10.1371/journal.ppat.1006500] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
65 Lam WKJ, Jiang P, Chan KCA, Peng W, Shang H, Heung MMS, Cheng SH, Zhang H, Tse OYO, Raghupathy R, Ma BBY, Hui EP, Chan ATC, Woo JKS, Chiu RWK, Lo YMD. Methylation analysis of plasma DNA informs etiologies of Epstein-Barr virus-associated diseases. Nat Commun 2019;10:3256. [PMID: 31332191 DOI: 10.1038/s41467-019-11226-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
66 Sawada L, Vallinoto ACR, Brasil-Costa I. Regulation of the Immune Checkpoint Indoleamine 2,3-Dioxygenase Expression by Epstein-Barr Virus. Biomolecules 2021;11:1792. [PMID: 34944437 DOI: 10.3390/biom11121792] [Reference Citation Analysis]
67 Yin H, Qu J, Peng Q, Gan R. Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis. Med Microbiol Immunol 2019;208:573-83. [PMID: 30386928 DOI: 10.1007/s00430-018-0570-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
68 Li Y, Shi F, Hu J, Xie L, Zhao L, Tang M, Luo X, Ye M, Zheng H, Zhou M, Liu N, Bode AM, Fan J, Zhou J, Gao Q, Qiu S, Wu W, Zhang X, Liao W, Cao Y. Stabilization of p18 by deubiquitylase CYLD is pivotal for cell cycle progression and viral replication. NPJ Precis Oncol 2021;5:14. [PMID: 33654169 DOI: 10.1038/s41698-021-00153-8] [Reference Citation Analysis]
69 Greijer AE, Ramayanti O, Verkuijlen SA, Novalić Z, Juwana H, Middeldorp JM. Quantitative multi-target RNA profiling in Epstein-Barr virus infected tumor cells. J Virol Methods 2017;241:24-33. [PMID: 27993616 DOI: 10.1016/j.jviromet.2016.12.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
70 Liu WN, Fong SY, Tan WWS, Tan SY, Liu M, Cheng JY, Lim S, Suteja L, Huang EK, Chan JKY, Iyer NG, Yeong JPS, Lim DW, Chen Q. Establishment and Characterization of Humanized Mouse NPC-PDX Model for Testing Immunotherapy. Cancers (Basel) 2020;12:E1025. [PMID: 32331230 DOI: 10.3390/cancers12041025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
71 Li F, Freed D, Heidecker G, Galli J, Durr E, Wang D. A novel high throughput assay to quantify Epstein-Barr virus neutralizing antibody activity against B-cell and epithelial cell infections for vaccine and therapeutic developments. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.04.102] [Reference Citation Analysis]
72 Murer A, Rühl J, Zbinden A, Capaul R, Hammerschmidt W, Chijioke O, Münz C. MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In Vivo. mBio 2019;10:e01941-18. [PMID: 30647153 DOI: 10.1128/mBio.01941-18] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
73 Singh RK, Bose D, Robertson ES. HIF1α-Regulated Expression of the Fatty Acid Binding Protein Family Is Important for Hypoxic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus. J Virol 2021;95:e02063-20. [PMID: 33789996 DOI: 10.1128/JVI.02063-20] [Reference Citation Analysis]
74 Gujer C, Murer A, Müller A, Vanoaica D, Sutter K, Jacque E, Fournier N, Kalchschmidt J, Zbinden A, Capaul R, Dzionek A, Mondon P, Dittmer U, Münz C. Plasmacytoid dendritic cells respond to Epstein-Barr virus infection with a distinct type I interferon subtype profile. Blood Adv 2019;3:1129-44. [PMID: 30952679 DOI: 10.1182/bloodadvances.2018025536] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
75 Li H, Li Y, Hu J, Liu S, Luo X, Tang M, Bode AM, Dong Z, Liu X, Liao W, Cao Y. (-)-Epigallocatechin-3-gallate inhibits EBV lytic replication via targeting LMP1-mediated MAPK signal axes. Oncol Res 2021. [PMID: 33629943 DOI: 10.3727/096504021X16135618512563] [Reference Citation Analysis]
76 Chen YP, Yin JH, Li WF, Li HJ, Chen DP, Zhang CJ, Lv JW, Wang YQ, Li XM, Li JY, Zhang PP, Li YQ, He QM, Yang XJ, Lei Y, Tang LL, Zhou GQ, Mao YP, Wei C, Xiong KX, Zhang HB, Zhu SD, Hou Y, Sun Y, Dean M, Amit I, Wu K, Kuang DM, Li GB, Liu N, Ma J. Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma. Cell Res 2020;30:1024-42. [PMID: 32686767 DOI: 10.1038/s41422-020-0374-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 16.5] [Reference Citation Analysis]
77 Abounouh K, Aitraise I, Benabou A, Boussakri I, Doumir MA, El Boussairi C, El Idrissi S, El Mahdaoui C, Qouar DE, Ennahal A, Fathi S, Hafidi M, Lachker L, Ratib C, Tanouti IA, Maaroufi A, Benjelloun S, Guessous F, Pineau P, Ezzikouri S. Virus-associated human cancers in Moroccan population: From epidemiology to prospective research. Infect Genet Evol 2019;75:103990. [PMID: 31386915 DOI: 10.1016/j.meegid.2019.103990] [Reference Citation Analysis]
78 Hau PM, Tsao SW. Epstein-Barr Virus Hijacks DNA Damage Response Transducers to Orchestrate Its Life Cycle. Viruses 2017;9:E341. [PMID: 29144413 DOI: 10.3390/v9110341] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
79 Shi Z, Zhang M. Emerging Roles for the Gut Microbiome in Lymphoid Neoplasms. Clin Med Insights Oncol 2021;15:11795549211024197. [PMID: 34211309 DOI: 10.1177/11795549211024197] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Torres K, Landeros N, Wichmann IA, Polakovicova I, Aguayo F, Corvalan AH. EBV miR-BARTs and human lncRNAs: Shifting the balance in competing endogenous RNA networks in EBV-associated gastric cancer. Biochim Biophys Acta Mol Basis Dis 2021;1867:166049. [PMID: 33401001 DOI: 10.1016/j.bbadis.2020.166049] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
81 Zheng S, Matskova L, Zhou X, Xiao X, Huang G, Zhang Z, Ernberg I. Downregulation of adipose triglyceride lipase by EB viral-encoded LMP2A links lipid accumulation to increased migration in nasopharyngeal carcinoma. Mol Oncol 2020;14:3234-52. [PMID: 33064888 DOI: 10.1002/1878-0261.12824] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
82 Al Sidairi H, Binkhamis K, Jackson C, Roberts C, Heinstein C, MacDonald J, Needle R, Hatchette TF, LeBlanc JJ. Comparison of two automated instruments for Epstein-Barr virus serology in a large adult hospital and implementation of an Epstein-Barr virus nuclear antigen-based testing algorithm. J Med Microbiol 2017;66:1628-34. [PMID: 29034860 DOI: 10.1099/jmm.0.000616] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
83 Lino CNR, Ghosh S. Epstein-Barr Virus in Inborn Immunodeficiency-More Than Infection. Cancers (Basel) 2021;13:4752. [PMID: 34638238 DOI: 10.3390/cancers13194752] [Reference Citation Analysis]
84 Hu T, Lin CY, Xie SH, Chen GH, Lu YQ, Ling W, Huang QH, Liu Q, Cao SM. Smoking can increase nasopharyngeal carcinoma risk by repeatedly reactivating Epstein-Barr Virus: An analysis of a prospective study in southern China. Cancer Med 2019;8:2561-71. [PMID: 30843658 DOI: 10.1002/cam4.2083] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
85 Bazot Q, Paschos K, Allday MJ. Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the STK39 Gene in B Cells Infected by EBV. J Virol 2018;92:e01918-17. [PMID: 29367247 DOI: 10.1128/JVI.01918-17] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
86 Lei F, Lei T, Huang Y, Yang M, Liao M, Huang W. Radio-Susceptibility of Nasopharyngeal Carcinoma: Focus on Epstein- Barr Virus, MicroRNAs, Long Non-Coding RNAs and Circular RNAs. Curr Mol Pharmacol 2020;13:192-205. [PMID: 31880267 DOI: 10.2174/1874467213666191227104646] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
87 Yang B, Fang X, Kong J. Engineered Microneedles for Interstitial Fluid Cell‐Free DNA Capture and Sensing Using Iontophoretic Dual‐Extraction Wearable Patch. Adv Funct Mater 2020;30:2000591. [DOI: 10.1002/adfm.202000591] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
88 Rodriguez CN, Iqbal MS, Robinson M, Burns G, Greystoke A. [A Rare Case of Non-small Cell Lung Carcinoma Squamous Phenotype with Epstein-Barr Virus Positivity with Prolonged Response to both Chemotherapy and Radiotherapy]. Zhongguo Fei Ai Za Zhi 2021;24:526-8. [PMID: 34275518 DOI: 10.3779/j.issn.1009-3419.2021.101.15] [Reference Citation Analysis]
89 Tsai MS, Fogarty U, Byrne AW, O'Keeffe J, Newman C, Macdonald DW, Buesching CD. Effects of Mustelid gammaherpesvirus 1 (MusGHV-1) Reactivation in European Badger (Meles meles) Genital Tracts on Reproductive Fitness. Pathogens 2020;9:E769. [PMID: 32962280 DOI: 10.3390/pathogens9090769] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
90 Xiao Z, Chen Z. Deciphering nasopharyngeal carcinoma pathogenesis via proteomics. Expert Rev Proteomics 2019;16:475-85. [PMID: 31056975 DOI: 10.1080/14789450.2019.1615891] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
91 Luo X, Hong L, Cheng C, Li N, Zhao X, Shi F, Liu J, Fan J, Zhou J, Bode AM, Cao Y. DNMT1 mediates metabolic reprogramming induced by Epstein-Barr virus latent membrane protein 1 and reversed by grifolin in nasopharyngeal carcinoma. Cell Death Dis 2018;9:619. [PMID: 29795311 DOI: 10.1038/s41419-018-0662-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
92 Mardanpour K, Rahbar M, Mardanpour S, Khazaei S, Rezaei M. Co-expression of Epstein-Barr virus-encoded RNA1 and viral latent membrane protein 1 in osteosarcoma: A novel insight of predictive markers. Tumour Biol 2020;42:1010428320974247. [PMID: 33234011 DOI: 10.1177/1010428320974247] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
93 Aguayo F, Boccardo E, Corvalán A, Calaf GM, Blanco R. Interplay between Epstein-Barr virus infection and environmental xenobiotic exposure in cancer. Infect Agent Cancer 2021;16:50. [PMID: 34193233 DOI: 10.1186/s13027-021-00391-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Silva M, Brunner V, Tschurtschenthaler M. Microbiota and Colorectal Cancer: From Gut to Bedside. Front Pharmacol 2021;12:760280. [PMID: 34658896 DOI: 10.3389/fphar.2021.760280] [Reference Citation Analysis]
95 Shan Y, Zhou P, Zhou Q, Yang L. Extracellular Vesicles in the Progression and Therapeutic Resistance of Nasopharyngeal Carcinoma. Cancers 2022;14:2289. [DOI: 10.3390/cancers14092289] [Reference Citation Analysis]
96 Rose EC, Tse TY, Oates AW, Jackson K, Pfeiffer S, Donahoe SL, Setyo L, Barrs VR, Beatty JA, Pesavento PA. Oropharyngeal Shedding of Gammaherpesvirus DNA by Cats, and Natural Infection of Salivary Epithelium. Viruses 2022;14:566. [DOI: 10.3390/v14030566] [Reference Citation Analysis]
97 Huang JT, Chen JN, Gong LP, Bi YH, Liang J, Zhou L, He D, Shao CK. Identification of virus-encoded circular RNA. Virology 2019;529:144-51. [PMID: 30710798 DOI: 10.1016/j.virol.2019.01.014] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 11.3] [Reference Citation Analysis]
98 Mrozek-Gorska P, Buschle A, Pich D, Schwarzmayr T, Fechtner R, Scialdone A, Hammerschmidt W. Epstein-Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection. Proc Natl Acad Sci U S A 2019;116:16046-55. [PMID: 31341086 DOI: 10.1073/pnas.1901314116] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 16.3] [Reference Citation Analysis]
99 Li X, Zhang W. Expression of PD-L1 in EBV-associated malignancies. Int Immunopharmacol 2021;95:107553. [PMID: 33765613 DOI: 10.1016/j.intimp.2021.107553] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
100 Dudaniec K, Westendorf K, Nössner E, Uckert W. Generation of Epstein-Barr Virus Antigen-Specific T Cell Receptors Recognizing Immunodominant Epitopes of LMP1, LMP2A, and EBNA3C for Immunotherapy. Hum Gene Ther 2021. [PMID: 33798008 DOI: 10.1089/hum.2020.283] [Reference Citation Analysis]
101 Tsutsumi N, Qu Q, Mavri M, Baggesen MS, Maeda S, Waghray D, Berg C, Kobilka BK, Rosenkilde MM, Skiniotis G, Garcia KC. Structural basis for the constitutive activity and immunomodulatory properties of the Epstein-Barr virus-encoded G protein-coupled receptor BILF1. Immunity 2021;54:1405-1416.e7. [PMID: 34216564 DOI: 10.1016/j.immuni.2021.06.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Heawchaiyaphum C, Iizasa H, Ekalaksananan T, Burassakarn A, Kiyono T, Kanehiro Y, Yoshiyama H, Pientong C. Epstein-Barr Virus Infection of Oral Squamous Cells. Microorganisms 2020;8:E419. [PMID: 32188127 DOI: 10.3390/microorganisms8030419] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
103 Lu T, Guo Q, Lin K, Chen H, Chen Y, Xu Y, Lin C, Su Y, Chen Y, Chen M, Zheng Y, Ye Y, Lin S, Zong J, Pan J. Circulating Epstein-Barr virus microRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma. Cancer Sci 2020;111:1711-23. [PMID: 32155300 DOI: 10.1111/cas.14381] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
104 Gain C, Malik S, Bhattacharjee S, Ghosh A, Robertson ES, Das BB, Saha A. Proteasomal inhibition triggers viral oncoprotein degradation via autophagy-lysosomal pathway. PLoS Pathog 2020;16:e1008105. [PMID: 32092124 DOI: 10.1371/journal.ppat.1008105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
105 Qin C, Huang Y, Feng Y, Li M, Guo N, Rao H. Clinicopathological features and EBV infection status of lymphoma in children and adolescents in South China: a retrospective study of 662 cases. Diagn Pathol 2018;13:17. [PMID: 29482573 DOI: 10.1186/s13000-018-0693-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
106 Szymula A, Palermo RD, Bayoumy A, Groves IJ, Ba Abdullah M, Holder B, White RE. Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naïve B cells, and facilitates recruitment of transcription factors to the viral genome. PLoS Pathog 2018;14:e1006890. [PMID: 29462212 DOI: 10.1371/journal.ppat.1006890] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
107 Rani A, Jakhmola S, Karnati S, Parmar HS, Chandra Jha H. Potential entry receptors for human γ-herpesvirus into epithelial cells: A plausible therapeutic target for viral infections. Tumour Virus Res 2021;12:200227. [PMID: 34800753 DOI: 10.1016/j.tvr.2021.200227] [Reference Citation Analysis]
108 Li L, Ma BBY, Chan ATC, Chan FKL, Murray P, Tao Q. Epstein-Barr Virus-Induced Epigenetic Pathogenesis of Viral-Associated Lymphoepithelioma-Like Carcinomas and Natural Killer/T-Cell Lymphomas. Pathogens 2018;7:E63. [PMID: 30022006 DOI: 10.3390/pathogens7030063] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
109 Kim KD, Tanizawa H, De Leo A, Vladimirova O, Kossenkov A, Lu F, Showe LC, Noma KI, Lieberman PM. Epigenetic specifications of host chromosome docking sites for latent Epstein-Barr virus. Nat Commun 2020;11:877. [PMID: 32054837 DOI: 10.1038/s41467-019-14152-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
110 Huang JT, Chen JN, Bi YH, Gong LP, Zhang JY, DU Y, Shao CK. Comparative Transcriptome Provides a Systematic Perspective on Epstein-Barr Virus-Associated Gastric Carcinoma Cell Lines. Onco Targets Ther 2021;14:5169-82. [PMID: 34720592 DOI: 10.2147/OTT.S332513] [Reference Citation Analysis]
111 Zhang S, Pei Y, Lang F, Sun K, Singh RK, Lamplugh ZL, Saha A, Robertson ES. EBNA3C facilitates RASSF1A downregulation through ubiquitin-mediated degradation and promoter hypermethylation to drive B-cell proliferation. PLoS Pathog 2019;15:e1007514. [PMID: 30615685 DOI: 10.1371/journal.ppat.1007514] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
112 Leung A, Trac C, Kato H, Costello KR, Chen Z, Natarajan R, Schones DE. LTRs activated by Epstein-Barr virus-induced transformation of B cells alter the transcriptome. Genome Res 2018;28:1791-8. [PMID: 30381291 DOI: 10.1101/gr.233585.117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
113 Hernández DM, Valderrama S, Gualtero S, Hernández C, López M, Herrera MV, Solano J, Fiorentino S, Quijano S. Loss of T-Cell Multifunctionality and TCR-Vβ Repertoire Against Epstein-Barr Virus Is Associated With Worse Prognosis and Clinical Parameters in HIV+ Patients. Front Immunol 2018;9:2291. [PMID: 30337929 DOI: 10.3389/fimmu.2018.02291] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
114 Zhao M, Nanbo A, Sun L, Lin Z. Extracellular Vesicles in Epstein-Barr Virus' Life Cycle and Pathogenesis. Microorganisms 2019;7:E48. [PMID: 30754656 DOI: 10.3390/microorganisms7020048] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
115 Cao Y. EBV based cancer prevention and therapy in nasopharyngeal carcinoma. NPJ Precis Oncol 2017;1:10. [PMID: 29872698 DOI: 10.1038/s41698-017-0018-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
116 Gnanasundram SV, Pyndiah S, Daskalogianni C, Armfield K, Nylander K, Wilson JB, Fåhraeus R. PI3Kδ activates E2F1 synthesis in response to mRNA translation stress. Nat Commun 2017;8:2103. [PMID: 29235459 DOI: 10.1038/s41467-017-02282-w] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
117 Ramayanti O, Verkuijlen SAWM, Novianti P, Scheepbouwer C, Misovic B, Koppers-Lalic D, van Weering J, Beckers L, Adham M, Martorelli D, Middeldorp JM, Pegtel DM. Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV-infections. Int J Cancer 2019;144:2555-66. [PMID: 30411781 DOI: 10.1002/ijc.31967] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
118 Martinez T, Shapiro M, Bhaduri-McIntosh S, MacCarthy T. Evolutionary effects of the AID/APOBEC family of mutagenic enzymes on human gamma-herpesviruses. Virus Evol 2019;5:vey040. [PMID: 30792902 DOI: 10.1093/ve/vey040] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
119 Coghill AE, Pfeiffer RM, Proietti C, Hsu WL, Chien YC, Lekieffre L, Krause L, Teng A, Pablo J, Yu KJ, Lou PJ, Wang CP, Liu Z, Chen CJ, Middeldorp J, Mulvenna J, Bethony J, Hildesheim A, Doolan DL. Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan. Clin Cancer Res 2018;24:1305-14. [PMID: 29301829 DOI: 10.1158/1078-0432.CCR-17-1929] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 6.8] [Reference Citation Analysis]
120 Bridgewater HE, Date KL, O'Neil JD, Hu C, Arrand JR, Dawson CW, Young LS. The Epstein-Barr Virus-Encoded EBNA1 Protein Activates the Bone Morphogenic Protein (BMP) Signalling Pathway to Promote Carcinoma Cell Migration. Pathogens 2020;9:E594. [PMID: 32708289 DOI: 10.3390/pathogens9070594] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
121 Huang SCM, Tsao SW, Tsang CM. Interplay of Viral Infection, Host Cell Factors and Tumor Microenvironment in the Pathogenesis of Nasopharyngeal Carcinoma. Cancers (Basel) 2018;10:E106. [PMID: 29617291 DOI: 10.3390/cancers10040106] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
122 Ooft ML, van Ipenburg J, van de Loo RJM, de Jong R, Moelans CB, de Bree R, de Herdt MJ, Koljenović S, de Jong RB, Hardillo J, Willems SM. Differences in cancer gene copy number alterations between Epstein-Barr virus-positive and Epstein-Barr virus-negative nasopharyngeal carcinoma. Head & Neck 2018;40:1986-98. [DOI: 10.1002/hed.25195] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
123 Navari M, Etebari M, Ibrahimi M, Leoncini L, Piccaluga PP. Pathobiologic Roles of Epstein-Barr Virus-Encoded MicroRNAs in Human Lymphomas. Int J Mol Sci 2018;19:E1168. [PMID: 29649101 DOI: 10.3390/ijms19041168] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
124 Camargo MC, Kim KM, Matsuo K, Torres J, Liao LM, Morgan D, Michel A, Waterboer T, Song M, Gulley ML, Dominguez RL, Yatabe Y, Kim S, Cortes-Martinez G, Lissowska J, Zabaleta J, Pawlita M, Rabkin CS. Circulating Antibodies against Epstein-Barr Virus (EBV) and p53 in EBV-Positive and -Negative Gastric Cancer. Cancer Epidemiol Biomarkers Prev 2020;29:414-9. [PMID: 31719065 DOI: 10.1158/1055-9965.EPI-19-0790] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
125 Lee SH, Choi SJ, Choi W, Cho S, Cho M, Kim DS, Kang BW, Kim JG, Lee YM, Cho H, Kang H. Cisplatin Resistance in Epstein-Barr-Virus-Associated Gastric Carcinoma Acquired through ATM Methylation. Cancers (Basel) 2021;13:4252. [PMID: 34503060 DOI: 10.3390/cancers13174252] [Reference Citation Analysis]
126 Wilms T, Khan G, Coates PJ, Sgaramella N, Fåhraeus R, Hassani A, Philip PS, Norberg Spaak L, Califano L, Colella G, Olofsson K, Loizou C, Franco R, Nylander K. No evidence for the presence of Epstein-Barr virus in squamous cell carcinoma of the mobile tongue. PLoS One 2017;12:e0184201. [PMID: 28926591 DOI: 10.1371/journal.pone.0184201] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
127 Wang YQ, Chen L, Mao YP, Li YQ, Jiang W, Xu SY, Zhang Y, Chen YP, Li XM, He QM, He SW, Yang XJ, Lei Y, Zhao Y, Yun JP, Liu N, Li Y, Ma J. Prognostic value of immune score in nasopharyngeal carcinoma using digital pathology. J Immunother Cancer 2020;8:e000334. [PMID: 32690665 DOI: 10.1136/jitc-2019-000334] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
128 Murray P, Ibrahim M. Role of EBV in Classical Hodgkin Lymphoma. In: Hudnall SD, Küppers R, editors. Precision Molecular Pathology of Hodgkin Lymphoma. Cham: Springer International Publishing; 2018. pp. 91-109. [DOI: 10.1007/978-3-319-68094-1_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
129 Davis AM, Rapley A, Dawson CW, Young LS, Morris MA. The EBV-Encoded Oncoprotein, LMP1, Recruits and Transforms Fibroblasts via an ERK-MAPK-Dependent Mechanism. Pathogens 2021;10:982. [PMID: 34451446 DOI: 10.3390/pathogens10080982] [Reference Citation Analysis]
130 Bai H, Yang J, Meng S, Liu C. Oral Microbiota-Driven Cell Migration in Carcinogenesis and Metastasis. Front Cell Infect Microbiol 2022;12:864479. [DOI: 10.3389/fcimb.2022.864479] [Reference Citation Analysis]
131 Liu W, Luo B. The impact of EBV on the epigenetics of gastric carcinoma. Future Virology 2020;15:183-93. [DOI: 10.2217/fvl-2019-0148] [Reference Citation Analysis]
132 Ferressini Gerpe NM, Vistarop AG, Moyano A, De Matteo E, Preciado MV, Chabay PA. Distinctive EBV infection characteristics in children from a developing country. Int J Infect Dis 2020;93:139-45. [PMID: 32004689 DOI: 10.1016/j.ijid.2020.01.044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
133 Biggi AFB, Elgui de Oliveira D. The Epstein-Barr Virus Hacks Immune Checkpoints: Evidence and Consequences for Lymphoproliferative Disorders and Cancers. Biomolecules 2022;12:397. [DOI: 10.3390/biom12030397] [Reference Citation Analysis]
134 Fuentes-Mattei E, Giza DE, Shimizu M, Ivan C, Manning JT, Tudor S, Ciccone M, Kargin OA, Zhang X, Mur P, do Amaral NS, Chen M, Tarrand JJ, Lupu F, Ferrajoli A, Keating MJ, Vasilescu C, Yeung SJ, Calin GA. Plasma Viral miRNAs Indicate a High Prevalence of Occult Viral Infections. EBioMedicine 2017;20:182-92. [PMID: 28465156 DOI: 10.1016/j.ebiom.2017.04.018] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
135 McHugh D, Caduff N, Murer A, Engelmann C, Deng Y, Zdimerova H, Zens K, Chijioke O, Münz C. Infection and immune control of human oncogenic γ-herpesviruses in humanized mice. Philos Trans R Soc Lond B Biol Sci 2019;374:20180296. [PMID: 30955487 DOI: 10.1098/rstb.2018.0296] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
136 Vangipuram R, Tyring SK. AIDS-Associated Malignancies. Cancer Treat Res 2019;177:1-21. [PMID: 30523619 DOI: 10.1007/978-3-030-03502-0_1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
137 Lange PT, Damania B. Modeling oncogenic herpesvirus infections in humanized mice. Curr Opin Virol 2020;44:90-6. [PMID: 32784124 DOI: 10.1016/j.coviro.2020.07.005] [Reference Citation Analysis]
138 Ong LTC, Parnell GP, Afrasiabi A, Stewart GJ, Swaminathan S, Booth DR. Transcribed B lymphocyte genes and multiple sclerosis risk genes are underrepresented in Epstein-Barr Virus hypomethylated regions. Genes Immun 2020;21:91-9. [PMID: 31619767 DOI: 10.1038/s41435-019-0089-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
139 Angerilli V, Galuppini F, Pennelli G, Fanelli GN, d'Amore ESG, Michelotto M, Pilati P, Spolverato G, Pucciarelli S, Scarpa M, Farinati F, Savarino E, Realdon S, Lonardi S, Bergamo F, Loupakis F, Dei Tos AP, Vanoli A, Fassan M. Epstein-Barr virus associated gastric dysplasia: a new rare entity? Virchows Arch 2021. [PMID: 34537878 DOI: 10.1007/s00428-021-03206-2] [Reference Citation Analysis]
140 Choi SJ, Jung SW, Huh S, Cho H, Kang H. Phylogenetic comparison of Epstein-Barr virus genomes. J Microbiol 2018;56:525-33. [PMID: 29948828 DOI: 10.1007/s12275-018-8039-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
141 Perez-Chacon G, Vincent-Fabert C, Zapata JM. Editorial: Mouse Models of B Cell Malignancies. Front Immunol 2021;12:789901. [PMID: 34777400 DOI: 10.3389/fimmu.2021.789901] [Reference Citation Analysis]
142 Reguraman N, Hassani A, Philip P, Khan G. Uncovering early events in primary Epstein-Barr virus infection using a rabbit model. Sci Rep 2021;11:21220. [PMID: 34707156 DOI: 10.1038/s41598-021-00668-x] [Reference Citation Analysis]
143 Chang A, Schlafer D, Flowers CR, Allen PB. Investigational PD-1 inhibitors in HL and NHL and biomarkers for predictors of response and outcome. Expert Opin Investig Drugs 2018;27:55-70. [PMID: 29228840 DOI: 10.1080/13543784.2018.1416091] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
144 Vrzalikova K, Sunmonu T, Reynolds G, Murray P. Contribution of Epstein⁻Barr Virus Latent Proteins to the Pathogenesis of Classical Hodgkin Lymphoma. Pathogens 2018;7:E59. [PMID: 29954084 DOI: 10.3390/pathogens7030059] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
145 Styles CT, Bazot Q, Parker GA, White RE, Paschos K, Allday MJ. EBV epigenetically suppresses the B cell-to-plasma cell differentiation pathway while establishing long-term latency. PLoS Biol 2017;15:e2001992. [PMID: 28771465 DOI: 10.1371/journal.pbio.2001992] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 5.6] [Reference Citation Analysis]
146 Soldan SS, Anderson EM, Frase DM, Zhang Y, Caruso LB, Wang Y, Deakyne JS, Gewurz BE, Tempera I, Lieberman PM, Messick TE. EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein-Barr virus-associated gastric cancer. Gastric Cancer 2021;24:1076-88. [PMID: 33929613 DOI: 10.1007/s10120-021-01193-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
147 Wen Y, Xu H, Han J, Jin R, Chen H. How Does Epstein–Barr Virus Interact With Other Microbiomes in EBV-Driven Cancers? Front Cell Infect Microbiol 2022;12:852066. [DOI: 10.3389/fcimb.2022.852066] [Reference Citation Analysis]
148 Young LS. A novel Epstein-Barr virus subtype associated with nasopharyngeal carcinoma found in South China. Cancer Commun (Lond) 2020;40:60-2. [PMID: 32077639 DOI: 10.1002/cac2.12006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
149 Cavallari I, Scattolin G, Silic-Benussi M, Raimondi V, D'Agostino DM, Ciminale V. Mitochondrial Proteins Coded by Human Tumor Viruses. Front Microbiol 2018;9:81. [PMID: 29467726 DOI: 10.3389/fmicb.2018.00081] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
150 Li Z, Tsai M, Shumilov A, Baccianti F, Tsao SW, Poirey R, Delecluse H. Epstein–Barr virus ncRNA from a nasopharyngeal carcinoma induces an inflammatory response that promotes virus production. Nat Microbiol 2019;4:2475-86. [DOI: 10.1038/s41564-019-0546-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
151 Li X, Akinyemi IA, You JK, Rezaei MA, Li C, McIntosh MT, Del Poeta M, Bhaduri-McIntosh S. A Mechanism-Based Targeted Screen To Identify Epstein-Barr Virus-Directed Antiviral Agents. J Virol 2020;94:e01179-20. [PMID: 32796077 DOI: 10.1128/JVI.01179-20] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
152 Zhang A, Zhong G, Wang L, Cai R, Han R, Xu C, Chen S, Sun P, Chen H. Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma. Cancer Cell Int 2021;21:518. [PMID: 34583688 DOI: 10.1186/s12935-021-02217-y] [Reference Citation Analysis]
153 Asakawa Y, Okabe A, Fukuyo M, Li W, Ikeda E, Mano Y, Funata S, Namba H, Fujii T, Kita K, Matsusaka K, Kaneda A. Epstein-Barr virus-positive gastric cancer involves enhancer activation through activating transcription factor 3. Cancer Sci 2020;111:1818-28. [PMID: 32119176 DOI: 10.1111/cas.14370] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
154 Pei Y, Xiang Z, Wen K, Tu CR, Wang X, Zhang Y, Mu X, Liu Y, Tu W. CD137 Costimulation Enhances the Antitumor Activity of Vγ9Vδ2-T Cells in IL-10-Mediated Immunosuppressive Tumor Microenvironment. Front Immunol 2022;13:872122. [DOI: 10.3389/fimmu.2022.872122] [Reference Citation Analysis]
155 Dai YC, Liao YT, Juan YT, Cheng YY, Su MT, Su YZ, Liu HC, Tsai CH, Lee CP, Chen MR. The Novel Nuclear Targeting and BFRF1-Interacting Domains of BFLF2 Are Essential for Efficient Epstein-Barr Virus Virion Release. J Virol 2020;94:e01498-19. [PMID: 31694953 DOI: 10.1128/JVI.01498-19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
156 Hu J, Li H, Luo X, Li Y, Bode A, Cao Y. The role of oxidative stress in EBV lytic reactivation, radioresistance and the potential preventive and therapeutic implications: REDOX control of EBV lytic reactivation and therapeutic opportunities. Int J Cancer 2017;141:1722-9. [DOI: 10.1002/ijc.30816] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
157 Murata T, Sugimoto A, Inagaki T, Yanagi Y, Watanabe T, Sato Y, Kimura H. Molecular Basis of Epstein-Barr Virus Latency Establishment and Lytic Reactivation. Viruses 2021;13:2344. [PMID: 34960613 DOI: 10.3390/v13122344] [Reference Citation Analysis]
158 Dheekollu J, Wiedmer A, Ayyanathan K, Deakyne JS, Messick TE, Lieberman PM. Cell-cycle-dependent EBNA1-DNA crosslinking promotes replication termination at oriP and viral episome maintenance. Cell 2021;184:643-654.e13. [PMID: 33482082 DOI: 10.1016/j.cell.2020.12.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
159 Hosoi H, Mushino T, Nakashima K, Kuriyama K, Tamura S, Murata S, Imadome KI, Ohshima K, Sonoki T. Composite Epstein-Barr Virus-associated T-lymphoblastic and Peripheral T-cell Lymphomas: A Clonal Study. Intern Med 2021;60:2119-23. [PMID: 33551410 DOI: 10.2169/internalmedicine.6572-20] [Reference Citation Analysis]
160 Hassani A, Khan G. Epstein-Barr Virus and miRNAs: Partners in Crime in the Pathogenesis of Multiple Sclerosis? Front Immunol 2019;10:695. [PMID: 31001286 DOI: 10.3389/fimmu.2019.00695] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
161 Fukayama M, Abe H, Kunita A, Shinozaki-Ushiku A, Matsusaka K, Ushiku T, Kaneda A. Thirty years of Epstein-Barr virus-associated gastric carcinoma. Virchows Arch 2020;476:353-65. [PMID: 31836926 DOI: 10.1007/s00428-019-02724-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
162 Djaoud Z, Parham P. Dimorphism in the TCRγ-chain repertoire defines 2 types of human immunity to Epstein-Barr virus. Blood Adv 2020;4:1198-205. [PMID: 32211881 DOI: 10.1182/bloodadvances.2019001179] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
163 Fish K, Longnecker R. EBV germinates lymphoma from the germinal center in a battle with T and NK cells. Proc Natl Acad Sci U S A 2017;114:4571-3. [PMID: 28442562 DOI: 10.1073/pnas.1704102114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
164 Ashraf S, Al-Maweri SA, Alaizari N, Umair A, Ariffin Z, Alhajj MN, Kassim S, Awan KH. The association between Epstein-Barr virus and oral lichen planus: A systematic review and meta-analysis. J Oral Pathol Med 2020;49:969-76. [PMID: 32746493 DOI: 10.1111/jop.13093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
165 Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation. Pathogens 2021;10:763. [PMID: 34204243 DOI: 10.3390/pathogens10060763] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
166 Pei Y, Singh RK, Shukla SK, Lang F, Zhang S, Robertson ES. Epstein-Barr Virus Nuclear Antigen 3C Facilitates Cell Proliferation by Regulating Cyclin D2. J Virol 2018;92:e00663-18. [PMID: 29997218 DOI: 10.1128/JVI.00663-18] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
167 Oleynikova NA, Danilova NV, Grimuta MO, Malkov PG. Epstein-Barr Virus in the Development of Colorectal Cancer (Review). Sovrem Tekhnologii Med 2021;13:82-91. [PMID: 34603767 DOI: 10.17691/stm2021.13.4.09] [Reference Citation Analysis]
168 Montes-Mojarro IA, Kim WY, Fend F, Quintanilla-Martinez L. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis. Semin Diagn Pathol 2020;37:32-46. [PMID: 31889602 DOI: 10.1053/j.semdp.2019.12.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
169 Carvalho AS, Cuco CM, Lavareda C, Miguel F, Ventura M, Almeida S, Pinto P, de Abreu TT, Rodrigues LV, Seixas S, Bárbara C, Azkargorta M, Elortza F, Semedo J, Field JK, Mota L, Matthiesen R. Bronchoalveolar Lavage Proteomics in Patients with Suspected Lung Cancer. Sci Rep 2017;7:42190. [PMID: 28169345 DOI: 10.1038/srep42190] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
170 Messick TE, Smith GR, Soldan SS, McDonnell ME, Deakyne JS, Malecka KA, Tolvinski L, van den Heuvel APJ, Gu BW, Cassel JA, Tran DH, Wassermann BR, Zhang Y, Velvadapu V, Zartler ER, Busson P, Reitz AB, Lieberman PM. Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth. Sci Transl Med 2019;11:eaau5612. [PMID: 30842315 DOI: 10.1126/scitranslmed.aau5612] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 16.5] [Reference Citation Analysis]
171 Zhang HJ, Tian J, Qi XK, Xiang T, He GP, Zhang H, Yu X, Zhang X, Zhao B, Feng QS, Chen MY, Zeng MS, Zeng YX, Feng L. Epstein-Barr virus activates F-box protein FBXO2 to limit viral infectivity by targeting glycoprotein B for degradation. PLoS Pathog 2018;14:e1007208. [PMID: 30052682 DOI: 10.1371/journal.ppat.1007208] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
172 Bhattacharjee S, Bose P, Patel K, Roy SG, Gain C, Gowda H, Robertson ES, Saha A. Transcriptional and epigenetic modulation of autophagy promotes EBV oncoprotein EBNA3C induced B-cell survival. Cell Death Dis 2018;9:605. [PMID: 29789559 DOI: 10.1038/s41419-018-0668-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
173 Wen L, Zhao F, Qiu Y, Cheng S, Sun JY, Fang W, Rayner S, McVoy MA, Jiang XJ, Tang Q, Li FC, Hu F, Luo MH. Human cytomegalovirus DNA and immediate early protein 1/2 are highly associated with glioma and prognosis. Protein Cell 2020;11:525-33. [PMID: 32189197 DOI: 10.1007/s13238-020-00696-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
174 Zhang J, Du Y, Gong L, Shao Y, Wen J, Sun L, He D, Guo J, Chen J, Shao C. EBV-Induced CXCL8 Upregulation Promotes Vasculogenic Mimicry in Gastric Carcinoma via NF-κB Signaling. Front Cell Infect Microbiol 2022;12:780416. [DOI: 10.3389/fcimb.2022.780416] [Reference Citation Analysis]
175 Lorenzetti MA, Mosna MJ, De Matteo EN, García Lombardi M, Colli SL, Preciado MV. Overexpression of survivin in pediatric Hodgkin lymphoma tumor cells: Characterization of protein expression and splice-variants transcription profile. Exp Mol Pathol 2019;108:24-31. [PMID: 30876863 DOI: 10.1016/j.yexmp.2019.03.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
176 Gao L, Han H, Wang H, Cao L, Feng WH. IL-10 knockdown with siRNA enhances the efficacy of Doxorubicin chemotherapy in EBV-positive tumors by inducing lytic cycle via PI3K/p38 MAPK/NF-kB pathway. Cancer Lett 2019;462:12-22. [PMID: 31352079 DOI: 10.1016/j.canlet.2019.07.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
177 Farrell JA, Yetsko K, Whitmore L, Whilde J, Eastman CB, Ramia DR, Thomas R, Linser P, Creer S, Burkhalter B, Schnitzler C, Duffy DJ. Environmental DNA monitoring of oncogenic viral shedding and genomic profiling of sea turtle fibropapillomatosis reveals unusual viral dynamics. Commun Biol 2021;4:565. [PMID: 33980988 DOI: 10.1038/s42003-021-02085-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
178 Zhang K, Zhang Y, Maharjan Y, Sugiokto FG, Wan J, Li R. Caspases Switch off the m6A RNA Modification Pathway to Foster the Replication of a Ubiquitous Human Tumor Virus. mBio 2021;12:e0170621. [PMID: 34425696 DOI: 10.1128/mBio.01706-21] [Reference Citation Analysis]
179 Yu F, Syn NL, Lu Y, Chong QY, Lai J, Tan WJ, Goh BC, MacAry PA, Wang L, Loh KS. Characterization and Establishment of a Novel EBV Strain Simultaneously Associated With Nasopharyngeal Carcinoma and B-Cell Lymphoma. Front Oncol 2021;11:626659. [PMID: 33898307 DOI: 10.3389/fonc.2021.626659] [Reference Citation Analysis]
180 Zhang C, Tan Q, Li S, Shen L, Zhang J, Liu Y, Yang W, Lu Z. Induction of EBV latent membrane protein-2A (LMP2A)-specific T cells and construction of individualized TCR-engineered T cells for EBV-associated malignancies. J Immunother Cancer 2021;9:e002516. [PMID: 34210819 DOI: 10.1136/jitc-2021-002516] [Reference Citation Analysis]
181 He Y, Zhou T, Yang D, Jia Y, Yuan L, Zhang W, Wang T, Liao Y, Xue W, Zhang J, Zheng X, Li X, Zhang P, Zhang S, Hu Y, Wang F, Cho WC, Ma J, Sun Y, Jia W. Prognostic Value of Oral Epstein–Barr Virus DNA Load in Locoregionally Advanced Nasopharyngeal Carcinoma. Front Mol Biosci 2022;8:757644. [DOI: 10.3389/fmolb.2021.757644] [Reference Citation Analysis]
182 Li N, Yang L, Qi XK, Lin YX, Xie X, He GP, Feng QS, Liu LR, Xie X, Zeng YX, Feng L. BET bromodomain inhibitor JQ1 preferentially suppresses EBV-positive nasopharyngeal carcinoma cells partially through repressing c-Myc. Cell Death Dis 2018;9:761. [PMID: 29988031 DOI: 10.1038/s41419-018-0789-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
183 Caruso A, Ceramella J, Iacopetta D, Saturnino C, Mauro MV, Bruno R, Aquaro S, Sinicropi MS. Carbazole Derivatives as Antiviral Agents: An Overview. Molecules 2019;24:E1912. [PMID: 31109016 DOI: 10.3390/molecules24101912] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 8.7] [Reference Citation Analysis]
184 Tsao SW, Tsang CM, Lo KW. Epstein-Barr virus infection and nasopharyngeal carcinoma. Philos Trans R Soc Lond B Biol Sci. 2017;372:20160270. [PMID: 28893937 DOI: 10.1098/rstb.2016.0270] [Cited by in Crossref: 140] [Cited by in F6Publishing: 157] [Article Influence: 35.0] [Reference Citation Analysis]
185 Morris MA, Laverick L, Wei W, Davis AM, O'Neill S, Wood L, Wright J, Dawson CW, Young LS. The EBV-Encoded Oncoprotein, LMP1, Induces an Epithelial-to-Mesenchymal Transition (EMT) via Its CTAR1 Domain through Integrin-Mediated ERK-MAPK Signalling. Cancers (Basel) 2018;10:E130. [PMID: 29723998 DOI: 10.3390/cancers10050130] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
186 Hong J, Wei D, Zhong L, Wu Q, Chen K, Zhang W, Yang Y, Chen J, Xia N, Zhang X, Chen Y. Glycoprotein B Antibodies Completely Neutralize EBV Infection of B Cells. Front Immunol 2022;13:920467. [PMID: 35711430 DOI: 10.3389/fimmu.2022.920467] [Reference Citation Analysis]
187 Münz C. Latency and lytic replication in Epstein-Barr virus-associated oncogenesis. Nat Rev Microbiol 2019;17:691-700. [PMID: 31477887 DOI: 10.1038/s41579-019-0249-7] [Cited by in Crossref: 84] [Cited by in F6Publishing: 83] [Article Influence: 28.0] [Reference Citation Analysis]
188 Wan C, Tai J, Zhang J, Guo Y, Zhu Q, Ling D, Gu F, Gan J, Zhu C, Wang Y, Liu S, Wei F, Cai Q. Silver nanoparticles selectively induce human oncogenic γ-herpesvirus-related cancer cell death through reactivating viral lytic replication. Cell Death Dis 2019;10:392. [PMID: 31113937 DOI: 10.1038/s41419-019-1624-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
189 Zhang J, Jia L, Tsang CM, Tsao SW. EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma. In: Cai Q, Yuan Z, Lan K, editors. Infectious Agents Associated Cancers: Epidemiology and Molecular Biology. Singapore: Springer; 2017. pp. 75-90. [DOI: 10.1007/978-981-10-5765-6_6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
190 Zhao B, Zhang X, Krummenacher C, Song S, Gao L, Zhang H, Xu M, Feng L, Feng Q, Zeng M, Xu Y, Zeng Y. Immunization With Fc-Based Recombinant Epstein-Barr Virus gp350 Elicits Potent Neutralizing Humoral Immune Response in a BALB/c Mice Model. Front Immunol 2018;9:932. [PMID: 29765376 DOI: 10.3389/fimmu.2018.00932] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
191 Awan FM, Yang BB, Naz A, Hanif A, Ikram A, Obaid A, Malik A, Janjua HA, Ali A, Sharif S. The emerging role and significance of circular RNAs in viral infections and antiviral immune responses: possible implication as theranostic agents. RNA Biol 2021;18:1-15. [PMID: 32615049 DOI: 10.1080/15476286.2020.1790198] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
192 Zanelli M, Sanguedolce F, Palicelli A, Zizzo M, Martino G, Caprera C, Fragliasso V, Soriano A, Valle L, Ricci S, Cavazza A, Merli F, Pileri SA, Ascani S. EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 1). Cancers (Basel) 2021;13:4578. [PMID: 34572803 DOI: 10.3390/cancers13184578] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
193 Strycharz-Dudziak M, Kiełczykowska M, Drop B, Świątek Ł, Kliszczewska E, Musik I, Polz-Dacewicz M. Total Antioxidant Status (TAS), Superoxide Dismutase (SOD), and Glutathione Peroxidase (GPx) in Oropharyngeal Cancer Associated with EBV Infection. Oxid Med Cell Longev 2019;2019:5832410. [PMID: 31360295 DOI: 10.1155/2019/5832410] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
194 Hong J, Zhong L, Zheng Q, Wu Q, Zha Z, Wei D, Chen H, Zhang W, Zhang S, Huang Y, Chen K, Chen J, Li S, Zeng MS, Zeng YX, Xia N, Zhang X, Xu M, Chen Y. A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge In Vivo. J Virol 2022;:e0007522. [PMID: 35348362 DOI: 10.1128/jvi.00075-22] [Reference Citation Analysis]
195 Ziegler P, Tian Y, Bai Y, Abrahamsson S, Bäckerholm A, Reznik AS, Green A, Moore JA, Lee SE, Myerburg MM, Park HJ, Tang KW, Shair KHY. A primary nasopharyngeal three-dimensional air-liquid interface cell culture model of the pseudostratified epithelium reveals differential donor- and cell type-specific susceptibility to Epstein-Barr virus infection. PLoS Pathog 2021;17:e1009041. [PMID: 33914843 DOI: 10.1371/journal.ppat.1009041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
196 Chen K, Wang M, Zhang R, Li J. Detection of Epstein-Barr virus encoded RNA in fixed cells and tissues using CRISPR/Cas-mediated RCasFISH. Anal Biochem 2021;625:114211. [PMID: 33915117 DOI: 10.1016/j.ab.2021.114211] [Reference Citation Analysis]
197 Pharaon RR, Xing Y, Agulnik M, Villaflor VM. The Role of Immunotherapy to Overcome Resistance in Viral-Associated Head and Neck Cancer. Front Oncol 2021;11:649963. [PMID: 34336649 DOI: 10.3389/fonc.2021.649963] [Reference Citation Analysis]
198 Lee N. The many ways Epstein-Barr virus takes advantage of the RNA tool kit. RNA Biol 2021;18:759-66. [PMID: 33517840 DOI: 10.1080/15476286.2021.1875184] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
199 Shafiee A, Shamsi S, Kohandel Gargari O, Beiky M, Allahkarami MM, Miyanaji AB, Aghajanian S, Mozhgani SH. EBV associated T- and NK-cell lymphoproliferative diseases: A comprehensive overview of clinical manifestations and novel therapeutic insights. Rev Med Virol 2022;:e2328. [PMID: 35122349 DOI: 10.1002/rmv.2328] [Reference Citation Analysis]
200 Kaye D, Isidori A. Current Challenges in Hematology: Awareness, Prevention, Equity. Front Oncol 2021;11:653020. [PMID: 33987089 DOI: 10.3389/fonc.2021.653020] [Reference Citation Analysis]
201 Jakhmola S, Upadhyay A, Jain K, Mishra A, Jha HC. Herpesviruses and the hidden links to Multiple Sclerosis neuropathology. J Neuroimmunol 2021;358:577636. [PMID: 34174587 DOI: 10.1016/j.jneuroim.2021.577636] [Reference Citation Analysis]
202 Velapasamy S, Dawson CW, Young LS, Paterson IC, Yap LF. The Dynamic Roles of TGF-β Signalling in EBV-Associated Cancers. Cancers (Basel) 2018;10:E247. [PMID: 30060514 DOI: 10.3390/cancers10080247] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
203 Wang L, Mai ZM, Ngan RK, Ng WT, Lin JH, Kwong DL, Chiang SC, Yuen KT, Ng AW, Ip DK, Chan YH, Lee AW, Lung ML, Ho SY, Lam TH. Dose-Response Reduction in Risk of Nasopharyngeal Carcinoma From Smoking Cessation: A Multicenter Case-Control Study in Hong Kong, China. Front Oncol 2021;11:699241. [PMID: 34646762 DOI: 10.3389/fonc.2021.699241] [Reference Citation Analysis]
204 Han C, Sim SJ, Kim SH, Singh R, Hwang S, Kim YI, Park SH, Kim KH, Lee DG, Oh HS, Lee S, Kim YH, Choi BK, Kwon BS. Desensitized chimeric antigen receptor T cells selectively recognize target cells with enhanced antigen expression. Nat Commun 2018;9:468. [PMID: 29391449 DOI: 10.1038/s41467-018-02912-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
205 Shi Q, Zhang Y, Liu W, Xiao H, Qi Y, Li J, Luo B. Latent membrane protein 2A inhibits expression level of Smad2 through regulating miR‐155‐5p in EBV‐associated gastric cancer cell lines. J Med Virol 2019;92:96-106. [DOI: 10.1002/jmv.25579] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
206 Riggs JB, Medina EM, Perrenoud LJ, Bonilla DL, Clambey ET, van Dyk LF, Berg LJ. Optimized Detection of Acute MHV68 Infection With a Reporter System Identifies Large Peritoneal Macrophages as a Dominant Target of Primary Infection. Front Microbiol 2021;12:656979. [PMID: 33767688 DOI: 10.3389/fmicb.2021.656979] [Reference Citation Analysis]
207 Song L, Song M, Camargo MC, Van Duine J, Williams S, Chung Y, Kim KM, Lissowska J, Sivins A, Gao W, Karthikeyan K, Park J, Leja M, Cohen JI, LaBaer J, Qiu J, Rabkin CS. Identification of anti-Epstein-Barr virus (EBV) antibody signature in EBV-associated gastric carcinoma. Gastric Cancer 2021;24:858-67. [PMID: 33661412 DOI: 10.1007/s10120-021-01170-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
208 Jing FY, Zhou LM, Ning YJ, Wang XJ, Zhu YM. The Biological Function, Mechanism, and Clinical Significance of m6A RNA Modifications in Head and Neck Carcinoma: A Systematic Review. Front Cell Dev Biol 2021;9:683254. [PMID: 34136491 DOI: 10.3389/fcell.2021.683254] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
209 Harhaj EW, Shembade N. Lymphotropic Viruses: Chronic Inflammation and Induction of Cancers. Biology (Basel) 2020;9:E390. [PMID: 33182552 DOI: 10.3390/biology9110390] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
210 Vo MT, Choi YB. Herpesvirus Regulation of Selective Autophagy. Viruses 2021;13:820. [PMID: 34062931 DOI: 10.3390/v13050820] [Reference Citation Analysis]
211 Chung YL, Wu ML. Spatiotemporal homogeneity and distinctness of the T-cell receptor β-chain repertoires in Epstein-Barr virus-associated primary and metastatic nasopharyngeal carcinomas. Int J Cancer 2018;143:610-20. [PMID: 29468660 DOI: 10.1002/ijc.31336] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
212 Ma J, Huang L, Hu D, Zeng S, Han Y, Shen H. The role of the tumor microbe microenvironment in the tumor immune microenvironment: bystander, activator, or inhibitor? J Exp Clin Cancer Res 2021;40:327. [PMID: 34656142 DOI: 10.1186/s13046-021-02128-w] [Reference Citation Analysis]
213 Pimenoff VN, Houldcroft CJ, Rifkin RF, Underdown S. The Role of aDNA in Understanding the Coevolutionary Patterns of Human Sexually Transmitted Infections. Genes (Basel) 2018;9:E317. [PMID: 29941858 DOI: 10.3390/genes9070317] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
214 Chen WJ, Xu WN, Wang HY, Chen XX, Li XQ, Xie SH, Lin DF, Cao SM. Plasma Epstein-Barr virus DNA and risk of nasopharyngeal carcinoma in a prospective seropositive population. BMC Cancer 2021;21:651. [PMID: 34074258 DOI: 10.1186/s12885-021-08408-0] [Reference Citation Analysis]
215 Watanabe T, Sato Y, Masud HMAA, Takayama M, Matsuda H, Hara Y, Yanagi Y, Yoshida M, Goshima F, Murata T, Kimura H. Antitumor activity of cyclin-dependent kinase inhibitor alsterpaullone in Epstein-Barr virus-associated lymphoproliferative disorders. Cancer Sci 2020;111:279-87. [PMID: 31743514 DOI: 10.1111/cas.14241] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
216 Zhang K, Lv DW, Li R. B Cell Receptor Activation and Chemical Induction Trigger Caspase-Mediated Cleavage of PIAS1 to Facilitate Epstein-Barr Virus Reactivation. Cell Rep 2017;21:3445-57. [PMID: 29262325 DOI: 10.1016/j.celrep.2017.11.071] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
217 Yu F, Lu Y, Li Y, Uchio Y, Pangnguriseng UA, Kartika AV, Iizasa H, Yoshiyama H, Loh KS. Epstein-Barr Virus Infection of Pseudostratified Nasopharyngeal Epithelium Disrupts Epithelial Integrity. Cancers (Basel) 2020;12:E2722. [PMID: 32972034 DOI: 10.3390/cancers12092722] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
218 Ambinder RF. Epstein-Barr Virus-Associated Post-transplant Lymphoproliferative Disease. Recent Results Cancer Res 2021;217:197-207. [PMID: 33200367 DOI: 10.1007/978-3-030-57362-1_9] [Reference Citation Analysis]
219 Avilala J, Becnel D, Abdelghani R, Nanbo A, Kahn J, Li L, Lin Z. Role of Virally Encoded Circular RNAs in the Pathogenicity of Human Oncogenic Viruses. Front Microbiol 2021;12:657036. [PMID: 33959113 DOI: 10.3389/fmicb.2021.657036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
220 Ooft ML, van Ipenburg J, van Loo R, de Jong R, Moelans C, Braunius W, de Bree R, van Diest P, Koljenović S, Baatenburg de Jong R, Hardillo J, Willems SM. Molecular profile of nasopharyngeal carcinoma: analysing tumour suppressor gene promoter hypermethylation by multiplex ligation-dependent probe amplification. J Clin Pathol 2018;71:351-9. [DOI: 10.1136/jclinpath-2017-204661] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
221 Yang JJ, Sang W, Xu KL. [Research progress on targeted therapies of Epstein-Barr virus-associated lymphomas]. Zhonghua Xue Ye Xue Za Zhi 2019;40:261-4. [PMID: 30929400 DOI: 10.3760/cma.j.issn.0253-2727.2019.03.021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
222 Li W, Okabe A, Usui G, Fukuyo M, Matsusaka K, Rahmutulla B, Mano Y, Hoshii T, Funata S, Hiura N, Fukayama M, Tan P, Ushiku T, Kaneda A. Activation of EHF via STAT3 phosphorylation by LMP2A in Epstein-Barr virus-positive gastric cancer. Cancer Sci 2021;112:3349-62. [PMID: 34014591 DOI: 10.1111/cas.14978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
223 Tan GW, Visser L, Tan LP, van den Berg A, Diepstra A. The Microenvironment in Epstein-Barr Virus-Associated Malignancies. Pathogens 2018;7:E40. [PMID: 29652813 DOI: 10.3390/pathogens7020040] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
224 Lo AK, Dawson CW, Young LS, Lo KW. The role of metabolic reprogramming in γ-herpesvirus-associated oncogenesis. Int J Cancer 2017;141:1512-21. [PMID: 28542909 DOI: 10.1002/ijc.30795] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
225 Zhao M, Nanbo A, Becnel D, Qin Z, Morris GF, Li L, Lin Z. Ubiquitin Modification of the Epstein-Barr Virus Immediate Early Transactivator Zta. J Virol 2020;94:e01298-20. [PMID: 32847852 DOI: 10.1128/JVI.01298-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
226 Meng GQ, Wang JS, Wang YN, Wei N, Wang Z. Rituximab-containing immuno-chemotherapy regimens are effective for the elimination of EBV for EBV-HLH with only and mainly B lymphocytes of EBV infection. Int Immunopharmacol 2021;96:107606. [PMID: 33826999 DOI: 10.1016/j.intimp.2021.107606] [Reference Citation Analysis]
227 Deng XM, Zhao LZ, Liang XY, Li D, Yu L, Zhang FC, Zhang H, Liu ZY, Xu P. In vitro Studies and Clinical Observations Imply a Synergistic Effect Between Epstein-Barr Virus and Dengue Virus Infection. Front Microbiol 2021;12:691008. [PMID: 34220783 DOI: 10.3389/fmicb.2021.691008] [Reference Citation Analysis]
228 Montes-Mojarro IA, Fend F, Quintanilla-Martinez L. EBV and the Pathogenesis of NK/T Cell Lymphoma. Cancers (Basel) 2021;13:1414. [PMID: 33808787 DOI: 10.3390/cancers13061414] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
229 Toptan T, Abere B, Nalesnik MA, Swerdlow SH, Ranganathan S, Lee N, Shair KH, Moore PS, Chang Y. Circular DNA tumor viruses make circular RNAs. Proc Natl Acad Sci U S A 2018;115:E8737-45. [PMID: 30150410 DOI: 10.1073/pnas.1811728115] [Cited by in Crossref: 83] [Cited by in F6Publishing: 74] [Article Influence: 20.8] [Reference Citation Analysis]
230 Liu W, Song YY, Wang JY, Xiao H, Zhang Y, Luo B. Dysregulation of FOXO transcription factors in Epstein-Barr virus-associated gastric carcinoma. Virus Res 2020;276:197808. [PMID: 31712122 DOI: 10.1016/j.virusres.2019.197808] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
231 Yanagi Y, Watanabe T, Hara Y, Sato Y, Kimura H, Murata T. EBV Exploits RNA m6A Modification to Promote Cell Survival and Progeny Virus Production During Lytic Cycle. Front Microbiol 2022;13:870816. [DOI: 10.3389/fmicb.2022.870816] [Reference Citation Analysis]
232 Gondhowiardjo SA, Handoko, Adham M, Rachmadi L, Kodrat H, Tobing DL, Haryoga IM, Dwiyono AG, Kristian YA, Permata TBM, Oike T. Epstein–Barr Virus (EBV) Viral Load in Tumor Cells Did Not Predict Tumor Extensiveness in Nasopharyngeal Cancer. Microbiology Research 2021;12:150-6. [DOI: 10.3390/microbiolres12010011] [Reference Citation Analysis]
233 Roetman JJ, Apostolova MKI, Philip M. Viral and cellular oncogenes promote immune evasion. Oncogene 2022. [PMID: 35022539 DOI: 10.1038/s41388-021-02145-1] [Reference Citation Analysis]
234 Anastasiadou E, Stroopinsky D, Alimperti S, Jiao AL, Pyzer AR, Cippitelli C, Pepe G, Severa M, Rosenblatt J, Etna MP, Rieger S, Kempkes B, Coccia EM, Sui SJH, Chen CS, Uccini S, Avigan D, Faggioni A, Trivedi P, Slack FJ. Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas. Leukemia 2019;33:132-47. [PMID: 29946193 DOI: 10.1038/s41375-018-0178-x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 66] [Article Influence: 15.0] [Reference Citation Analysis]
235 Li J, Guo Y, Deng Y, Hu L, Li B, Deng S, Zhong J, Xie L, Shi S, Hong X, Zheng X, Cai M, Li M. Subcellular Localization of Epstein-Barr Virus BLLF2 and Its Underlying Mechanisms. Front Microbiol 2021;12:672192. [PMID: 34367081 DOI: 10.3389/fmicb.2021.672192] [Reference Citation Analysis]
236 Wang L, Laing J, Yan B, Zhou H, Ke L, Wang C, Narita Y, Zhang Z, Olson MR, Afzali B, Zhao B, Kazemian M. Epstein-Barr Virus Episome Physically Interacts with Active Regions of the Host Genome in Lymphoblastoid Cells. J Virol 2020;94:e01390-20. [PMID: 32999023 DOI: 10.1128/JVI.01390-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
237 Becnel D, Abdelghani R, Nanbo A, Avilala J, Kahn J, Li L, Lin Z. Pathogenic Role of Epstein-Barr Virus in Lung Cancers. Viruses 2021;13:877. [PMID: 34064727 DOI: 10.3390/v13050877] [Reference Citation Analysis]
238 Gillman ACT, Parker G, Allday MJ, Bazot Q. Epstein-Barr Virus Nuclear Antigen 3C Inhibits Expression of COBLL1 and the ADAM28-ADAMDEC1 Locus via Interaction with the Histone Lysine Demethylase KDM2B. J Virol 2018;92:e01362-18. [PMID: 30135119 DOI: 10.1128/JVI.01362-18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
239 Sharma R. A Systematic Examination of Burden of Childhood Cancers in 183 Countries: Estimates from GLOBOCAN 2018. Eur J Cancer Care (Engl) 2021;:e13438. [PMID: 33723880 DOI: 10.1111/ecc.13438] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
240 Zanella L, Riquelme I, Buchegger K, Abanto M, Ili C, Brebi P. A reliable Epstein-Barr Virus classification based on phylogenomic and population analyses. Sci Rep 2019;9:9829. [PMID: 31285478 DOI: 10.1038/s41598-019-45986-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
241 Tonoyan L, Vincent-Bugnas S, Olivieri CV, Doglio A. New Viral Facets in Oral Diseases: The EBV Paradox. Int J Mol Sci 2019;20:E5861. [PMID: 31766729 DOI: 10.3390/ijms20235861] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
242 Linke-Serinsöz E, Fend F, Quintanilla-Martinez L. Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) related lymphomas, pathology view point. Semin Diagn Pathol 2017;34:352-63. [PMID: 28506687 DOI: 10.1053/j.semdp.2017.04.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
243 Moss LI, Tompkins VS, Moss WN. Differential expression analysis comparing EBV uninfected to infected human cell lines identifies induced non-micro small non-coding RNAs. Noncoding RNA Res 2020;5:32-6. [PMID: 32154466 DOI: 10.1016/j.ncrna.2020.02.002] [Reference Citation Analysis]
244 Cao Y, Xie L, Shi F, Tang M, Li Y, Hu J, Zhao L, Zhao L, Yu X, Luo X, Liao W, Bode AM. Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study. Signal Transduct Target Ther 2021;6:15. [PMID: 33436584 DOI: 10.1038/s41392-020-00376-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
245 Lo AK, Dawson CW, Lung HL, Wong KL, Young LS. The Role of EBV-Encoded LMP1 in the NPC Tumor Microenvironment: From Function to Therapy. Front Oncol 2021;11:640207. [PMID: 33718235 DOI: 10.3389/fonc.2021.640207] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
246 Xiong J, Cui BW, Wang N, Dai YT, Zhang H, Wang CF, Zhong HJ, Cheng S, Ou-Yang BS, Hu Y, Zhang X, Xu B, Qian WB, Tao R, Yan F, Hu JD, Hou M, Ma XJ, Wang X, Liu YH, Zhu ZM, Huang XB, Liu L, Wu CY, Huang L, Shen YF, Huang RB, Xu JY, Wang C, Wu DP, Yu L, Li JF, Xu PP, Wang L, Huang JY, Chen SJ, Zhao WL. Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma. Cancer Cell 2020;37:403-419.e6. [PMID: 32183952 DOI: 10.1016/j.ccell.2020.02.005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 12.5] [Reference Citation Analysis]
247 Berditchevski F, Fennell E, Murray PG. Calcium-dependent signalling in B-cell lymphomas. Oncogene 2021;40:6321-8. [PMID: 34625709 DOI: 10.1038/s41388-021-02025-8] [Reference Citation Analysis]
248 Wang W, Zhang Y, Liu W, Xiao H, Zhang Q, Wang J, Luo B. LMP1–miR-146a–CXCR4 axis regulates cell proliferation, apoptosis and metastasis. Virus Research 2019;270:197654. [DOI: 10.1016/j.virusres.2019.197654] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
249 Kang YF, Zhang X, Yu XH, Zheng Q, Liu Z, Li JP, Sun C, Kong XW, Zhu QY, Chen HW, Huang Y, Xu M, Zhong Q, Zeng YX, Zeng MS. Immunization with a Self-Assembled Nanoparticle Vaccine Elicits Potent Neutralizing Antibody Responses against EBV Infection. Nano Lett 2021;21:2476-86. [PMID: 33683126 DOI: 10.1021/acs.nanolett.0c04687] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
250 Wang Y, Du S, Zhu C, Wang C, Yu N, Lin Z, Gan J, Guo Y, Huang X, He Y, Robertson E, Qu D, Wei F, Cai Q. STUB1 is targeted by the SUMO-interacting motif of EBNA1 to maintain Epstein-Barr Virus latency. PLoS Pathog 2020;16:e1008447. [PMID: 32176739 DOI: 10.1371/journal.ppat.1008447] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
251 Zhu QY, Shan S, Yu J, Peng SY, Sun C, Zuo Y, Zhong LY, Yan SM, Zhang X, Yang Z, Peng YJ, Shi X, Cao SM, Wang X, Zeng MS, Zhang L. A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus. Nat Commun 2021;12:6624. [PMID: 34785638 DOI: 10.1038/s41467-021-26912-6] [Reference Citation Analysis]
252 Mackrides N, Chapman J, Larson MC, Ramos JC, Toomey N, Lin P, Maurer MJ, Rafaelle M, Tan Y, Ikpatt O, Syrbu S, Ansell SM, Habermann TM, Link BK, Feldman AL, Lossos IS, Cerhan JR, Vega F. Prevalence, clinical characteristics and prognosis of EBV-positive follicular lymphoma. Am J Hematol 2019;94:E62-4. [PMID: 30474261 DOI: 10.1002/ajh.25357] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
253 Burton EM, Voyer J, Gewurz BE. Epstein-Barr virus latency programs dynamically sensitize B cells to ferroptosis. Proc Natl Acad Sci U S A 2022;119:e2118300119. [PMID: 35275790 DOI: 10.1073/pnas.2118300119] [Reference Citation Analysis]
254 Jin S, Li R, Chen MY, Yu C, Tang LQ, Liu YM, Li JP, Liu YN, Luo YL, Zhao Y, Zhang Y, Xia TL, Liu SX, Liu Q, Wang GN, You R, Peng JY, Li J, Han F, Wang J, Chen QY, Zhang L, Mai HQ, Gewurz BE, Zhao B, Young LS, Zhong Q, Bai F, Zeng MS. Single-cell transcriptomic analysis defines the interplay between tumor cells, viral infection, and the microenvironment in nasopharyngeal carcinoma. Cell Res 2020;30:950-65. [PMID: 32901110 DOI: 10.1038/s41422-020-00402-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
255 Lam WKJ, Ji L, Tse OYO, Cheng SH, Jiang P, Lee PHP, Lin SV, Hui EP, Ma BBY, Chan ATC, Chan KCA, Chiu RWK, Lo YMD. Sequencing Analysis of Plasma Epstein-Barr Virus DNA Reveals Nasopharyngeal Carcinoma-Associated Single Nucleotide Variant Profiles. Clin Chem 2020;66:598-605. [PMID: 32191318 DOI: 10.1093/clinchem/hvaa027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
256 Maple PA, Ascherio A, Cohen JI, Cutter G, Giovannoni G, Shannon-lowe C, Tanasescu R, Gran B. The Potential for EBV Vaccines to Prevent Multiple Sclerosis. Front Neurol 2022;13:887794. [DOI: 10.3389/fneur.2022.887794] [Reference Citation Analysis]
257 Tan KE, Ng WL, Marinov GK, Yu KH, Tan LP, Liau ES, Goh SY, Yeo KS, Yip KY, Lo KW, Khoo AS, Yap LF, Ea CK, Lim YY. Identification and characterization of a novel Epstein-Barr Virus-encoded circular RNA from LMP-2 Gene. Sci Rep 2021;11:14392. [PMID: 34257379 DOI: 10.1038/s41598-021-93781-w] [Reference Citation Analysis]
258 Kheir F, Zhao M, Strong MJ, Yu Y, Nanbo A, Flemington EK, Morris GF, Reiss K, Li L, Lin Z. Detection of Epstein-Barr Virus Infection in Non-Small Cell Lung Cancer. Cancers (Basel) 2019;11:E759. [PMID: 31159203 DOI: 10.3390/cancers11060759] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
259 Yajima M, Kakuta R, Saito Y, Kitaya S, Toyoda A, Ikuta K, Yasuda J, Ohta N, Kanda T. A global phylogenetic analysis of Japanese tonsil-derived Epstein-Barr virus strains using viral whole-genome cloning and long-read sequencing. J Gen Virol 2021;102. [PMID: 33433312 DOI: 10.1099/jgv.0.001549] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
260 García-Barchino MJ, Sarasquete ME, Panizo C, Morscio J, Martinez A, Alcoceba M, Fresquet V, Gonzalez-Farre B, Paiva B, Young KH, Robles EF, Roa S, Celay J, Larrayoz M, Rossi D, Gaidano G, Montes-Moreno S, Piris MA, Balanzategui A, Jimenez C, Rodriguez I, Calasanz MJ, Larrayoz MJ, Segura V, Garcia-Muñoz R, Rabasa MP, Yi S, Li J, Zhang M, Xu-Monette ZY, Puig-Moron N, Orfao A, Böttcher S, Hernandez-Rivas JM, Miguel JS, Prosper F, Tousseyn T, Sagaert X, Gonzalez M, Martinez-Climent JA. Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia. J Pathol 2018;245:61-73. [PMID: 29464716 DOI: 10.1002/path.5060] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
261 Shao Q, Liu T, Wang W, Liu T, Jin X, Chen Z. Promising Role of Emodin as Therapeutics to Against Viral Infections. Front Pharmacol 2022;13:902626. [DOI: 10.3389/fphar.2022.902626] [Reference Citation Analysis]
262 Židovec Lepej S, Matulić M, Gršković P, Pavlica M, Radmanić L, Korać P. miRNAs: EBV Mechanism for Escaping Host's Immune Response and Supporting Tumorigenesis. Pathogens 2020;9:E353. [PMID: 32397085 DOI: 10.3390/pathogens9050353] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
263 Liu W, Zhang Y, Luo B. Long Non-coding RNAs in Gammaherpesvirus Infections: Their Roles in Tumorigenic Mechanisms. Front Microbiol 2020;11:604536. [PMID: 33519750 DOI: 10.3389/fmicb.2020.604536] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
264 Gebre M, Nomburg JL, Gewurz BE. CRISPR-Cas9 Genetic Analysis of Virus-Host Interactions. Viruses 2018;10:E55. [PMID: 29385696 DOI: 10.3390/v10020055] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
265 Hong J, Wei D, Wu Q, Zhong L, Chen K, Huang Y, Zhang W, Chen J, Xia N, Zhang X, Chen Y. Antibody Generation and Immunogenicity Analysis of EBV gp42 N-Terminal Region. Viruses 2021;13:2380. [PMID: 34960650 DOI: 10.3390/v13122380] [Reference Citation Analysis]
266 Hau PM, Lung HL, Wu M, Tsang CM, Wong KL, Mak NK, Lo KW. Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma. Front Oncol 2020;10:600. [PMID: 32528868 DOI: 10.3389/fonc.2020.00600] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
267 Liu Y, Jiang Q, Liu X, Lin X, Tang Z, Liu C, Zhou J, Zhao M, Li X, Cheng Z, Li L, Xie Y, Liu Z, Fang W. Cinobufotalin powerfully reversed EBV-miR-BART22-induced cisplatin resistance via stimulating MAP2K4 to antagonize non-muscle myosin heavy chain IIA/glycogen synthase 3β/β-catenin signaling pathway. EBioMedicine 2019;48:386-404. [PMID: 31594754 DOI: 10.1016/j.ebiom.2019.08.040] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
268 Kanda T. EBV-Encoded Latent Genes. Adv Exp Med Biol 2018;1045:377-94. [PMID: 29896676 DOI: 10.1007/978-981-10-7230-7_17] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
269 Wu X, Zhou Z, Xu S, Liao C, Chen X, Li B, Peng J, Li D, Yang L. Extracellular vesicle packaged LMP1-activated fibroblasts promote tumor progression via autophagy and stroma-tumor metabolism coupling. Cancer Lett 2020;478:93-106. [PMID: 32160975 DOI: 10.1016/j.canlet.2020.03.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 11.5] [Reference Citation Analysis]
270 Gilardini Montani MS, Santarelli R, Granato M, Gonnella R, Torrisi MR, Faggioni A, Cirone M. EBV reduces autophagy, intracellular ROS and mitochondria to impair monocyte survival and differentiation. Autophagy 2019;15:652-67. [PMID: 30324853 DOI: 10.1080/15548627.2018.1536530] [Cited by in Crossref: 29] [Cited by in F6Publishing: 36] [Article Influence: 7.3] [Reference Citation Analysis]
271 Watanabe T, Sakaida K, Yoshida M, Masud HMAA, Sato Y, Goshima F, Kimura H, Murata T. The C-Terminus of Epstein-Barr Virus BRRF2 Is Required for its Proper Localization and Efficient Virus Production. Front Microbiol 2017;8:125. [PMID: 28197146 DOI: 10.3389/fmicb.2017.00125] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
272 Zhao S, Dong X, Ni X, Li L, Lu X, Zhang K, Gao Y. Exploration of a Novel Prognostic Risk Signature and Its Effect on the Immune Response in Nasopharyngeal Carcinoma. Front Oncol 2021;11:709931. [PMID: 34692486 DOI: 10.3389/fonc.2021.709931] [Reference Citation Analysis]
273 Zheng X, Huang Y, Li K, Luo R, Cai M, Yun J. Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein–Barr Virus-Associated Malignancies. Viruses 2022;14:1017. [DOI: 10.3390/v14051017] [Reference Citation Analysis]
274 Lo AK, Dawson CW, Lung HL, Wong KL, Young LS. The Therapeutic Potential of Targeting BARF1 in EBV-Associated Malignancies. Cancers (Basel) 2020;12:E1940. [PMID: 32708965 DOI: 10.3390/cancers12071940] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
275 Tsang C, Lo K, Nicholls JM, Huang S, Tsao S. Pathogenesis of Nasopharyngeal Carcinoma. Nasopharyngeal Carcinoma. Elsevier; 2019. pp. 45-64. [DOI: 10.1016/b978-0-12-814936-2.00003-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
276 Qiao Y, Zhao X, Liu J, Yang W. Epstein-Barr virus circRNAome as host miRNA sponge regulates virus infection, cell cycle, and oncogenesis. Bioengineered 2019;10:593-603. [PMID: 31668120 DOI: 10.1080/21655979.2019.1679698] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
277 Chen ZH, Yan SM, Chen XX, Zhang Q, Liu SX, Liu Y, Luo YL, Zhang C, Xu M, Zhao YF, Huang LY, Liu BL, Xia TL, Xu DZ, Liang Y, Chen YM, Wang W, Yuan SQ, Zhang HZ, Yun JP, Zhai WW, Zeng MS, Bai F, Zhong Q. The genomic architecture of EBV and infected gastric tissue from precursor lesions to carcinoma. Genome Med 2021;13:146. [PMID: 34493320 DOI: 10.1186/s13073-021-00963-2] [Reference Citation Analysis]
278 Sommermann T, Yasuda T, Ronen J, Wirtz T, Weber T, Sack U, Caeser R, Zhang J, Li X, Chu VT, Jauch A, Unger K, Hodson DJ, Akalin A, Rajewsky K. Functional interplay of Epstein-Barr virus oncoproteins in a mouse model of B cell lymphomagenesis. Proc Natl Acad Sci U S A 2020;117:14421-32. [PMID: 32522871 DOI: 10.1073/pnas.1921139117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
279 Zanelli M, Sanguedolce F, Palicelli A, Zizzo M, Martino G, Caprera C, Fragliasso V, Soriano A, Valle L, Ricci S, Gozzi F, Cimino L, Cavazza A, Merli F, Pileri SA, Ascani S. EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 2). Cancers (Basel) 2021;13:4527. [PMID: 34572754 DOI: 10.3390/cancers13184527] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
280 Peng X, Zhou Y, Tao Y, Liu S. Nasopharyngeal Carcinoma: The Role of the EGFR in Epstein-Barr Virus Infection. Pathogens 2021;10:1113. [PMID: 34578147 DOI: 10.3390/pathogens10091113] [Reference Citation Analysis]
281 Li M, Chen WJ, Yang J, Charvat H, Xie SH, Li T, Ling W, Lu YQ, Liu Q, Hong MH, Cao SM. Association between solid fuel use and seropositivity against Epstein-Barr virus in a high-risk area for nasopharyngeal carcinoma. Environ Pollut 2022;304:119184. [PMID: 35341821 DOI: 10.1016/j.envpol.2022.119184] [Reference Citation Analysis]
282 Abi-Rafeh J, Beamish IV, Haegert DG, Cournoyer D, Michel RP. Extranodal NK/T cell lymphoma and lymphomatoid granulomatosis in a patient with chronic lymphocytic leukaemia: Case report for a new perspective on Richter syndrome. Medicine (Baltimore) 2020;99:e20106. [PMID: 32384485 DOI: 10.1097/MD.0000000000020106] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
283 Teow SY, Yap HY, Peh SC. Epstein-Barr Virus as a Promising Immunotherapeutic Target for Nasopharyngeal Carcinoma Treatment. J Pathog 2017;2017:7349268. [PMID: 29464124 DOI: 10.1155/2017/7349268] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
284 Siddiqi UZ, Vaidya AS, Li X, Marcon E, Tsao SW, Greenblatt J, Frappier L. Identification of ARKL1 as a Negative Regulator of Epstein-Barr Virus Reactivation. J Virol 2019;93:e00989-19. [PMID: 31341047 DOI: 10.1128/JVI.00989-19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
285 Chakravorty A, Sugden B, Johannsen EC. An Epigenetic Journey: Epstein-Barr Virus Transcribes Chromatinized and Subsequently Unchromatinized Templates during Its Lytic Cycle. J Virol 2019;93:e02247-18. [PMID: 30700606 DOI: 10.1128/JVI.02247-18] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
286 Hsu WL, Chien YC, Huang YT, Yu KJ, Ko JY, Lin CY, Tsou YA, Leu YS, Liao LJ, Chang YL, Su JY, Liu Z, Wang CP, Terng SD, Hua CH, Lee JC, Yang TL, Kate Hsiao CH, Wu MS, Tsai MH, Liu MJ, Lou PJ, Hildesheim A, Chen CJ; GEV-NPC Study Group. Cigarette smoking increases the risk of nasopharyngeal carcinoma through the elevated level of IgA antibody against Epstein-Barr virus capsid antigen: A mediation analysis. Cancer Med 2020;9:1867-76. [PMID: 31925935 DOI: 10.1002/cam4.2832] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
287 Ambinder RF. A viral protein kinase drug target for tumors? J Clin Invest 2018;128:2197-8. [PMID: 29733293 DOI: 10.1172/JCI121080] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
288 Hulse M, Caruso LB, Madzo J, Tan Y, Johnson S, Tempera I. Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1. PLoS Pathog 2018;14:e1007394. [PMID: 30395643 DOI: 10.1371/journal.ppat.1007394] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
289 Dojcinov SD, Fend F, Quintanilla-Martinez L. EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts. Pathogens 2018;7:E28. [PMID: 29518976 DOI: 10.3390/pathogens7010028] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 11.0] [Reference Citation Analysis]
290 Lee HM, Sia APE, Li L, Sathasivam HP, Chan MSA, Rajadurai P, Tsang CM, Tsao SW, Murray PG, Tao Q, Paterson IC, Yap LF. Monoamine oxidase A is down-regulated in EBV-associated nasopharyngeal carcinoma. Sci Rep 2020;10:6115. [PMID: 32273550 DOI: 10.1038/s41598-020-63150-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
291 Tikhmyanova N, Tutton S, Martin KA, Lu F, Kossenkov AV, Paparoidamis N, Kenney S, Salvino JM, Lieberman PM. Small molecule perturbation of the CAND1-Cullin1-ubiquitin cycle stabilizes p53 and triggers Epstein-Barr virus reactivation. PLoS Pathog 2017;13:e1006517. [PMID: 28715492 DOI: 10.1371/journal.ppat.1006517] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
292 Basso M, Andreis S, Scaggiante R, Franchin E, Zago D, Biasolo MA, Del Vecchio C, Mengoli C, Sarmati L, Andreoni M, Palù G, Parisi SG. Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study. BMC Infect Dis 2018;18:683. [PMID: 30567494 DOI: 10.1186/s12879-018-3591-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
293 Bomken S, van der Werff Ten Bosch J, Attarbaschi A, Bacon CM, Borkhardt A, Boztug K, Fischer U, Hauck F, Kuiper RP, Lammens T, Loeffen J, Neven B, Pan-Hammarström Q, Quinti I, Seidel MG, Warnatz K, Wehr C, Lankester AC, Gennery AR. Current Understanding and Future Research Priorities in Malignancy Associated With Inborn Errors of Immunity and DNA Repair Disorders: The Perspective of an Interdisciplinary Working Group. Front Immunol 2018;9:2912. [PMID: 30619276 DOI: 10.3389/fimmu.2018.02912] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
294 Qu H, Chen M, Ge J, Zhang X, He S, Xiong F, Yan Q, Zhang S, Gong Z, Guo C, Wang F, Zeng Z, Li X, Li G, Xiong W, Wu X. A fluorescence strategy for circRNA quantification in tumor cells based on T7 nuclease-assisted cycling enzymatic amplification. Anal Chim Acta 2022;1189:339210. [PMID: 34815051 DOI: 10.1016/j.aca.2021.339210] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
295 Zhao L, Deng X, Li Y, Hu J, Xie L, Shi F, Tang M, Bode AM, Zhang X, Liao W, Cao Y. Conformational change of adenine nucleotide translocase-1 mediates cisplatin resistance induced by EBV-LMP1. EMBO Mol Med 2021;:e14072. [PMID: 34755470 DOI: 10.15252/emmm.202114072] [Reference Citation Analysis]
296 Xiang T, Lin YX, Ma W, Zhang HJ, Chen KM, He GP, Zhang X, Xu M, Feng QS, Chen MY, Zeng MS, Zeng YX, Feng L. Vasculogenic mimicry formation in EBV-associated epithelial malignancies. Nat Commun 2018;9:5009. [PMID: 30479336 DOI: 10.1038/s41467-018-07308-5] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 10.8] [Reference Citation Analysis]
297 Fournier B, Latour S. Immunity to EBV as revealed by immunedeficiencies. Curr Opin Immunol 2021;72:107-15. [PMID: 33989894 DOI: 10.1016/j.coi.2021.04.003] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
298 Hutcheson RL, Chakravorty A, Sugden B. Burkitt Lymphomas Evolve to Escape Dependencies on Epstein-Barr Virus. Front Cell Infect Microbiol 2020;10:606412. [PMID: 33505922 DOI: 10.3389/fcimb.2020.606412] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
299 Hosoi H, Niibori-Nambu A, Nah GSS, Bahirvani AG, Mok MMH, Sanda T, Kumar AP, Tenen DG, Ito Y, Sonoki T, Osato M. Super-enhancers for RUNX3 are required for cell proliferation in EBV-infected B cell lines. Gene 2021;774:145421. [PMID: 33444684 DOI: 10.1016/j.gene.2021.145421] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
300 Yan M, Zhang Y, Yang F, Ji L, Wang M, Wang W. Comparative study between chronic immune thrombocytopenia patients and healthy population on Epstein-Barr virus infection status by polymerase chain reaction. Expert Rev Hematol 2020;13:781-6. [PMID: 32498632 DOI: 10.1080/17474086.2020.1772746] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
301 Stanland LJ, Luftig MA. Molecular features and translational outlook for Epstein-Barr virus-associated gastric cancer. Future Virol 2018;13:803-18. [PMID: 34367314 DOI: 10.2217/fvl-2018-0071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
302 Klinakis A, Rampias T. TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection. EBioMedicine 2020;58:102905. [PMID: 32739866 DOI: 10.1016/j.ebiom.2020.102905] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
303 Ribeiro J, Malta M, Galaghar A, Afonso LP, Libânio D, Medeiros R, Dinis-Ribeiro M, Pimentel-Nunes P, Sousa H. Epstein-Barr virus is absent in gastric superficial neoplastic lesions. Virchows Arch 2019;475:757-62. [PMID: 31673776 DOI: 10.1007/s00428-019-02670-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
304 Burassakarn A, Srisathaporn S, Pientong C, Wongjampa W, Vatanasapt P, Patarapadungkit N, Ekalaksananan T. Exosomes-carrying Epstein-Barr virus-encoded small RNA-1 induces indoleamine 2, 3-dioxygenase expression in tumor-infiltrating macrophages of oral squamous-cell carcinomas and suppresses T-cell activity by activating RIG-I/IL-6/TNF-α pathway. Oral Oncol 2021;117:105279. [PMID: 33819809 DOI: 10.1016/j.oraloncology.2021.105279] [Reference Citation Analysis]
305 Lang F, Pei Y, Lamplugh ZL, Robertson ES. Molecular Biology of EBV in Relationship to HIV/AIDS-Associated Oncogenesis. Cancer Treat Res 2019;177:81-103. [PMID: 30523622 DOI: 10.1007/978-3-030-03502-0_4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
306 Wong KCW, Hui EP, Lo KW, Lam WKJ, Johnson D, Li L, Tao Q, Chan KCA, To KF, King AD, Ma BBY, Chan ATC. Nasopharyngeal carcinoma: an evolving paradigm. Nat Rev Clin Oncol 2021. [PMID: 34194007 DOI: 10.1038/s41571-021-00524-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
307 Wegner F, Lassalle F, Depledge DP, Balloux F, Breuer J. Co-evolution of sites under immune selection shapes Epstein-Barr Virus population structure. Mol Biol Evol 2019:msz152. [PMID: 31273385 DOI: 10.1093/molbev/msz152] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
308 Liu Z, Li H, Yu KJ, Xie SH, King AD, Ai QH, Chen WJ, Chen XX, Lu ZJ, Tang LQ, Wang L, Xie CM, Ling W, Lu YQ, Huang QH, Coghill AE, Fakhry C, Pfeiffer RM, Zeng YX, Cao SM, Hildesheim A. Comparison of new magnetic resonance imaging grading system with conventional endoscopy for the early detection of nasopharyngeal carcinoma. Cancer 2021;127:3403-12. [PMID: 34231883 DOI: 10.1002/cncr.33552] [Reference Citation Analysis]
309 Patel SS, Singh S, Sahu C, Ghoshal U, Verma H. A three year Seroepidemiological and molecular study of Epstein -Barr virus infection among different age groups with hematological malignancies in a Tertiary care centre of North India ( 2017 -2019). J Family Med Prim Care 2021;10:373-7. [PMID: 34017756 DOI: 10.4103/jfmpc.jfmpc_1594_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
310 Cooper RS, Georgieva ER, Borbat PP, Freed JH, Heldwein EE. Structural basis for membrane anchoring and fusion regulation of the herpes simplex virus fusogen gB. Nat Struct Mol Biol 2018;25:416-24. [PMID: 29728654 DOI: 10.1038/s41594-018-0060-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
311 Berenstein AJ, Lorenzetti MA, Preciado MV. Recombination rates along the entire Epstein Barr virus genome display a highly heterogeneous landscape. Infect Genet Evol 2018;65:96-103. [PMID: 30031929 DOI: 10.1016/j.meegid.2018.07.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
312 Dai DL, Li X, Wang L, Xie C, Jin Y, Zeng MS, Zuo Z, Xia TL. Identification of an N6-methyladenosine-mediated positive feedback loop that promotes Epstein-Barr virus infection. J Biol Chem 2021;296:100547. [PMID: 33741341 DOI: 10.1016/j.jbc.2021.100547] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
313 Hopcraft SE, Moody CA, Damania B. Air-Liquid Interface System To Understand Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma. mSphere 2018;3:e00350-18. [PMID: 30021881 DOI: 10.1128/mSphere.00350-18] [Reference Citation Analysis]
314 Nam MH, Hsieh YY, Chen BJ. EBV-positive low-grade follicular lymphoma transforming to EBV-negative high-grade B-cell lymphoma with MYC and BCL2 rearrangements. Pathology 2021:S0031-3025(21)00518-3. [PMID: 34872752 DOI: 10.1016/j.pathol.2021.09.009] [Reference Citation Analysis]
315 Rivera-Soto R, Damania B. Modulation of Angiogenic Processes by the Human Gammaherpesviruses, Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus. Front Microbiol 2019;10:1544. [PMID: 31354653 DOI: 10.3389/fmicb.2019.01544] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
316 Chen F, Huang X, Lv J, Wen D, Zhou G, Lin L, Kou J, Wu C, Chen Y, Zheng Z, Li Z, He X, Sun Y. Prognostic potential of liquid biopsy tracking in the posttreatment surveillance of patients with nonmetastatic nasopharyngeal carcinoma. Cancer 2020;126:2163-73. [DOI: 10.1002/cncr.32770] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
317 Kearns PKA. Prevention of MS Requires Intervention on the Causes of the Disease: Reconciling Genes, Epigenetics, and Epstein Barr Virus. Front Neurol 2022;13:817677. [PMID: 35273557 DOI: 10.3389/fneur.2022.817677] [Reference Citation Analysis]
318 Fülöp Á, Torma G, Moldován N, Szenthe K, Bánáti F, Almsarrhad IAA, Csabai Z, Tombácz D, Minárovits J, Boldogkői Z. Integrative profiling of Epstein-Barr virus transcriptome using a multiplatform approach. Virol J 2022;19:7. [PMID: 34991630 DOI: 10.1186/s12985-021-01734-6] [Reference Citation Analysis]
319 Yoon S, Ryu KH, Baek HJ, An HJ, Joo YH. Epstein-Barr virus-positive diffuse large B-cell lymphoma with human immunodeficiency virus mimicking complicated frontal sinusitis: A case report. World J Clin Cases 2021; 9(7): 1654-1660 [PMID: 33728309 DOI: 10.12998/wjcc.v9.i7.1654] [Reference Citation Analysis]
320 Lam WKJ, Chan KCA, Lo YMD. Plasma Epstein-Barr virus DNA as an archetypal circulating tumour DNA marker. J Pathol 2019;247:641-9. [PMID: 30714167 DOI: 10.1002/path.5249] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
321 Roy Chattopadhyay N, Chatterjee K, Tiwari N, Chakrabarti S, Sahu SK, Deb Roy S, Ghosh A, Reddy RR, Das P, Mal S, Karnar BB, Das AK, Tsering S, Riba K, Puii Z, Zomawia E, Singh YI, Suryawanshi AR, Kumar A, Ganguly D, Goswami C, Choudhuri T. TLR9 Polymorphisms Might Contribute to the Ethnicity Bias for EBV-Infected Nasopharyngeal Carcinoma. iScience 2020;23:100937. [PMID: 32179470 DOI: 10.1016/j.isci.2020.100937] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
322 Chen GH, Liu Z, Ji MF, Pfeiffer RM, Huang QH, Lu YQ, Xie SH, Lin CY, Chen WJ, Chen XX, Ling W, Fan YY, Yu X, Wu BH, Wei KR, Rao HL, Guo X, Hong MH, Ma J, Liu Q, Hildesheim A, Cao SM. Prospective assessment of a nasopharyngeal carcinoma risk score in a population undergoing screening. Int J Cancer 2020. [PMID: 33285002 DOI: 10.1002/ijc.33424] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
323 Kori M, Arga KY. Pathways involved in viral oncogenesis: New perspectives from virus-host protein interactomics. Biochim Biophys Acta Mol Basis Dis 2020;1866:165885. [PMID: 32574835 DOI: 10.1016/j.bbadis.2020.165885] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
324 Budisan L, Zanoaga O, Braicu C, Pirlog R, Covaliu B, Esanu V, Korban SS, Berindan-Neagoe I. Links between Infections, Lung Cancer, and the Immune System. Int J Mol Sci 2021;22:9394. [PMID: 34502312 DOI: 10.3390/ijms22179394] [Reference Citation Analysis]
325 Kang Y, He W, Ren C, Qiao J, Guo Q, Hu J, Xu H, Jiang X, Wang L. Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma. Signal Transduct Target Ther 2020;5:245. [PMID: 33093441 DOI: 10.1038/s41392-020-00340-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
326 Liu N, Shi F, Yang L, Liao W, Cao Y. Oncogenic viral infection and amino acid metabolism in cancer progression: Molecular insights and clinical implications. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022;1877:188724. [DOI: 10.1016/j.bbcan.2022.188724] [Reference Citation Analysis]
327 Polakovicova I, Jerez S, Wichmann IA, Sandoval-Bórquez A, Carrasco-Véliz N, Corvalán AH. Role of microRNAs and Exosomes in Helicobacter pylori and Epstein-Barr Virus Associated Gastric Cancers. Front Microbiol 2018;9:636. [PMID: 29675003 DOI: 10.3389/fmicb.2018.00636] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 9.0] [Reference Citation Analysis]
328 Khan G, Fitzmaurice C, Naghavi M, Ahmed LA. Global and regional incidence, mortality and disability-adjusted life-years for Epstein-Barr virus-attributable malignancies, 1990-2017. BMJ Open 2020;10:e037505. [PMID: 32868361 DOI: 10.1136/bmjopen-2020-037505] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
329 Naughton P, Healy M, Enright F, Lucey B. Infectious Mononucleosis: diagnosis and clinical interpretation. Br J Biomed Sci 2021;78:107-16. [PMID: 33721513 DOI: 10.1080/09674845.2021.1903683] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
330 Notarte KI, Senanayake S, Macaranas I, Albano PM, Mundo L, Fennell E, Leoncini L, Murray P. MicroRNA and Other Non-Coding RNAs in Epstein-Barr Virus-Associated Cancers. Cancers (Basel) 2021;13:3909. [PMID: 34359809 DOI: 10.3390/cancers13153909] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
331 Haas OA. Primary Immunodeficiency and Cancer Predisposition Revisited: Embedding Two Closely Related Concepts Into an Integrative Conceptual Framework. Front Immunol 2018;9:3136. [PMID: 30809233 DOI: 10.3389/fimmu.2018.03136] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
332 Liu Z, Sarathkumara YD, Chan JKC, Kwong YL, Lam TH, Ip DKM, Chiu BC, Xu J, Su YC, Proietti C, Cooper MM, Yu KJ, Bassig B, Liang R, Hu W, Ji BT, Coghill AE, Pfeiffer RM, Hildesheim A, Rothman N, Doolan DL, Lan Q. Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphoma. Sci Rep 2021;11:23664. [PMID: 34880297 DOI: 10.1038/s41598-021-02788-w] [Reference Citation Analysis]
333 Goswami R, Shair KHY, Gershburg E. Molecular diversity of IgG responses to Epstein-Barr virus proteins in asymptomatic Epstein-Barr virus carriers. J Gen Virol 2017;98:2343-50. [PMID: 28795661 DOI: 10.1099/jgv.0.000891] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]